# Intrinsically disordered RNA-binding motifs cooperate to catalyze RNA folding and drive phase separation

Annika Niedner-Boblenz, Thomas Monecke, Janosch Hennig, Melina

Klostermann, Mario Hofweber, Elena Davydova, André P Gerber, Irina

Anosova, Wieland Mayer, Marisa Müller, et al.

<figure><img src="image_1.png" /></figure>

## To cite this version:

Annika Niedner-Boblenz, Thomas Monecke, Janosch Hennig, Melina Klostermann, Mario Hofweber, et al. Intrinsically disordered RNA-binding motifs cooperate to catalyze RNA folding and drive phase separation. Nucleic Acids Research, 2024, pp.14205-14228. 10.1101/2024.03.27.586925. hal-04742818v2

HAL Id: hal-04742818

https://hal.science/hal-04742818v2

Submitted on 5 Nov 2025

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_2.png" /></figure>
Intrinsically disordered RNA-binding motifs cooperate to
catalyze RNA folding and drive phase separation

Annika Niedner-Boblenz<sup>1,2,†</sup>, Thomas Monecke<sup>③,†</sup>, Janosch Hennig<sup>①,4,5,6</sup>,
Melina Klostermann<sup>⑦,8</sup>, Mario Hofweber<sup>2</sup>, Elena Davydova<sup>1</sup>, André P. Gerber<sup>⑨</sup>,
Irina Anosova<sup>1,4</sup>, Wieland Mayer<sup>3</sup>, Marisa Müller<sup>1,10</sup>, Roland Gerhard Heym<sup>1</sup>, Robert Janowski<sup>1</sup>,
Jean-Christophe Paillart<sup>⑪</sup>, Dorothee Dormann<sup>2,12,13</sup>, Kathi Zarnack<sup>⑦,8</sup>, Michael Sattler<sup>1,4</sup> and
Dierk Niessing<sup>①,2,3,*</sup>

**Abstract**

RNA-binding proteins are essential for gene regulation and the spatial organization of cells. Here, we report that the yeast ribosome biogenesis factor Loc1p is an intrinsically disordered RNA-binding protein with eight repeating positively charged, unstructured nucleic acid binding (PUN) motifs. While a single of these previously undefined motifs stabilizes folded RNAs, multiple copies strongly cooperate to catalyze RNA folding. In the presence of RNA, these multivalent PUN motifs drive phase separation. Proteome-wide searches in pro- and eukaryotes for proteins with similar arrays of PUN motifs reveal a strong enrichment in RNA-mediated processes and DNA remodeling. Thus, PUN motifs are potentially involved in a large variety of RNA- and DNA-related processes by concentrating them in membraneless organelles. The general function and wide distribution of PUN motifs across species suggest that in an ancient 'RNA world' PUN-like motifs may have supported the correct folding of early ribozymes.

**Graphical abstract**

<figure><img src="image_3.png" /></figure>

<footnote n="1">¹Institute of Structural Biology, Molecular Targets and Therapeutics Center, Helmholtz Munich, Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany</footnote>

<footnote n="2">²Department of Anatomy and Cell Biology, Biomedical Center of the Ludwig-Maximilians University München, Großhaderner Str. 9, 82152 Planegg-Martinsried, Germany</footnote>

<footnote n="3">³Institute of Pharmaceutical Biotechnology, Ulm University, James-Franck-Ring N27, 89081 Ulm, Germany</footnote>

<footnote n="4">⁴Department of Bioscience and Bavarian NMR Center, TUM School of Natural Sciences, Technical University of Munich, Lichtenbergstrasse 4, 85747 Garching, Germany</footnote>

<footnote n="5">⁵Structural and Computational Biology Unit, European Molecular Biology Laboratory (EMBL), Meyerhofstr. 1, 69117 Heidelberg, Germany</footnote>

<footnote n="6">⁶Department of Biochemistry IV—Biophysical Chemistry, University of Bayreuth, Universitätstraße 30 / BGI, 95447 Bayreuth, Germany</footnote>

<footnote n="7">⁷Buchmann Institute for Molecular Life Sciences (BMLS) and Institute of Molecular Biosciences, Goethe University Frankfurt, Max-von-Laue-Str. 15, 60438 Frankfurt, Germany</footnote>

<footnote n="8">⁸Theodor-Boveri-Institut für Biowissenschaften, Lehrstuhl für Bioinformatik, Biozentrum, Julius-Maximilians-Universität Würzburg, Am Hubland, 97074 Würzburg, Germany</footnote>

<footnote n="9">⁹Department of Microbial Sciences, School of Biosciences, Faculty of Health and Medical Sciences, University of Surrey, Stag Hill Campus, 10AX01, Guildford GU2 7XH, UK</footnote>

<footnote n="10">¹⁰Department of Molecular Biology, Biomedical Center of the Ludwig-Maximilians University München, Großhaderner Str. 9, 82152 Planegg-Martinsried, Germany</footnote>

<footnote n="11">¹¹IBMC, Architecture et Réactivité de l'ARN, Université de Strasbourg, CNRS, 2 allée Konrad Roentgen, 67000 Strasbourg, France</footnote>

<footnote n="12">¹²Biocenter, Institute of Molecular Physiology, Johannes Gutenberg-Universität (JGU), Hanns-Hüsch-Weg 17, 55128 Mainz, Germany</footnote>

<footnote n="13">¹³Institute of Molecular Biology (IMB), Ackermannweg 4, 55128 Mainz, Germany</footnote>

<footnote>*To whom correspondence should be addressed. Tel: +49 731 50 23160; Email: dierk.niessing@uni-ulm.de</footnote>

<footnote>†The first two authors should be regarded as Joint First Authors.</footnote>
## Introduction

Biogenesis of eukaryotic ribosomes requires the correct processing and assembly of four ribosomal RNAs (rRNAs; 5S, 5.8S, 25S and 18S) with 79 ribosomal proteins. In the budding yeast *Saccharomyces cerevisiae*, this process is guided by 76 small nucleolar RNAs (snoRNAs) and >200 different assembly factors (1). Ribosomal proteins stabilize folded rRNAs, function as chaperones to favor the correct rRNA fold or alter the rRNA fold to create binding sites for other ribosomal proteins (2). In contrast to ribosomal proteins, so-called assembly factors are non-integral, associated components of the ribosome (1). They often share properties with ribosomal proteins, such as unusually high isoelectric points (Supplementary Table S1). However, assembly factors are functionally much more diverse, for instance including endo- and exonucleases, protein- and RNA-modifying enzymes, RNA helicases and other ATPases, GTPases, kinases and phosphatases, RNA-binding proteins and putative scaffolding proteins (3). Often, their individual molecular function has been assigned to a particular step of RNA processing, export or maturation, based on the observed depletion phenotypes.

In *S. cerevisiae*, the nucleolar RNA-binding protein Loc1p is required for efficient ribosome biogenesis (4). It has also been suggested to be necessary for the generation of distinct classes of ribosomes with different sets of ribosomal protein paralogs (5). In addition, Loc1p fulfills a second function. It supports ASH1 messenger RNA (mRNA) localization to the bud tip by stabilizing the formation of immature messenger ribonucleoprotein (mRNP) particles in the nucleus (6-8).

Loc1p is a constituent of pre-60S ribosomal particles (9-12) and co-purifies with Nop7, which functions in 90S and 66S ribosome biogenesis (4), and with the ribosomal protein Rpl43 (13,14). Consistently, a *loc1Δ* strain showed reduced 60S subunit levels and half-mer polyribosomes in sucrose gradients (15). A closer examination of rRNA processing in the *loc1Δ* strain revealed impaired cleavage at sites A₀, A₁ and A₂ (15). Nevertheless, a functional understanding of the molecular role of Loc1p in the biogenesis of ribosomes is still missing.

Here, we report that Loc1p is an intrinsically disordered protein with strong, ATP-independent RNA-annealing activity. We identified eight short, positively charged, unfolded nucleic acid binding (PUN) motifs in Loc1p, which cooperatively act as potent RNA annealers. Furthermore, multiple PUN motifs mediate RNA-driven phase separation, suggesting a role of PUN motif-containing proteins (PUN proteins) in the subcellular organization of RNAs. Several nuclear proteins involved in RNA metabolic processes and neurogenesis in higher eukaryotes are highly enriched with multiple PUN motifs. Together, these findings imply that PUN proteins are core constituents at the interface of protein-nucleic acid complexes across species. We speculate that in ancient times such short repetitive elements with PUN-like properties could have fostered the transition from purely RNA-based macromolecules to an RNP-dominated world.

## Materials and methods

### Protein expression and purification

Maltose-binding protein (MBP)-tagged and His₆-tagged Loc1p (UniProt ID P43586) was expressed and purified as previously described (6). Loc1p (1–20)₁₀ was expressed with

an N-terminal His₆ tag in *Escherichia coli* strain BL21 (DE3) Star. Expression and purification of Loc1p (1–20)₁₀ was identical to the procedure of wild-type Loc1p (6). Loc1p (3–15) was expressed with an N-terminal GST tag in *E. coli* strain BL21-Gold (DE3) pRARE using M9 minimal media supplemented with ¹⁵N-ammonium chloride and ¹³C-glucose. After induction with 0.25 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) in the mid-logarithmic growth phase, the cells were cultured for 16 h at 18°C and subsequently harvested. Cells were resuspended in lysis buffer [20 mM Na₂HPO₄/NaH₂PO₄, pH 7.4, 500 mM NaCl, EDTA-free cOmplete protease inhibitor (Roche), 0.4 mM phenyl-methylsulfonyl fluoride (PMSF)] and sonicated at 4°C. After centrifugation, the clarified supernatant was applied to a GSTrap FF sepharose column (GE Healthcare) and washed with high-salt buffer (1 M NaCl) and low-salt buffer (150 mM NaCl). The protein was digested with thrombin overnight at 4°C and further purified by cation-exchange chromatography. Peptide-containing fractions were pooled, dialyzed in water and lyophilized.

*Yersinia enterocolitica* Hfq (UniProt ID Q56928) was expressed N-terminally His₆-SUMO-tagged in *E. coli* strain ER2566. At the mid-logarithmic growth phase, the expression was induced by addition of 0.25 mM IPTG and cells were cultured for 16 h at 18°C and harvested. Cells were sonicated at 4°C in lysis buffer [100 mM HEPES, pH 8, 200 mM MgCl₂, 1 M NaCl, 1 mM dithiothreitol (DTT), EDTA-free cOmplete protease inhibitor (Roche)]. After centrifugation, the supernatant was applied to a HisTrap-FF sepharose column (GE Healthcare) and washed with low-salt buffer (500 mM NaCl) before the protein was eluted with 500 mM imidazole in low-salt buffer. The protein was further purified using size exclusion chromatography (Superdex S75; GE Healthcare).

Imp4p (UniProt ID P53941) was expressed His₆-SUMO-tagged in *E. coli* strain BL21 (DE3) Star. When cells reached the mid-logarithmic growth phase, expression was induced by addition of 0.25 mM IPTG. After 16 h of culture at 18°C, the cells were harvested and resuspended in lysis buffer (20 mM HEPES, pH 7.8, 500 mM NaCl, 1 mM DTT) before sonication was performed at 4°C. The suspension was centrifuged and the clarified supernatant applied to a HisTrap-FF sepharose column. After washing steps with high-salt buffer (1 M NaCl) and low-salt buffer (200 mM NaCl), the protein was eluted with 500 mM imidazole and further purified using size exclusion chromatography (Superose S12 column; GE Healthcare).

Coding sequences of Loc1p (1–20)₃, Loc1p (1–20)₅ and SRRM1 [serine/arginine repetitive matrix protein 1; amino acids (aa) 151–377] (UniProt ID Q8IYB3) were cloned into pGEX4T1 vector with an N-terminal GST tag followed by a thrombin cleavage site. Loc1p (1–20)₃, Loc1p (1–20)₅ and SRRM1 were expressed in *E. coli* BL21-Gold (DE3) pRARE using auto-inducing medium (16). The cells were grown for 4 h at 37°C and 18 h at 20°C, and then harvested at 10 000 × g and 4°C for 30 min. For each protein, the purification protocol was identical. The pellet from 2 l of culture was resuspended in buffer A (20 mM Tris, pH 8.5, 500 mM NaCl), supplemented with DNase I and EDTA-free protease inhibitor cocktail (Roche) to a total volume of 50 ml. After sonication, the lysate was clarified by centrifugation (20 000 × g, 30 min), loaded onto a 5-ml GST-trap column (GE Healthcare), equilibrated in buffer A and washed with 20 column volumes (CV) of buffer A. High-salt wash was implemented (10 CV; 20 mM Tris, pH 8.5, 1 M NaCl). GST-tagged protein was
eluted from the column in 10 CV linear glutathione gradient using buffer B (20 mM Tris, pH 8.5, 500 mM NaCl, 10 mM glutathione). Fractions with protein were combined and dia-lyzed against 20 mM Tris (pH 8.5), 150 mM NaCl and 2.5 mM CaCl₂ overnight at 4°C with thrombin added to remove the GST tag (1:100 ratio). Thrombin, uncleaved protein and cleaved GST were removed by applying everything onto a 5-ml SP column (GE Healthcare) equilibrated with 20 mM Tris (pH 8.0) and 50 mM NaCl buffer. Prior to loading the sample onto the SP column, sample buffer was exchanged to 20 mM Tris (pH 8.0) and 50 mM NaCl to decrease salt concentration. The protein of interest was eluted from the column in 10 CV linear salt gradient using 20 mM Tris (pH 8.0) and 1 M NaCl. The peak fractions were analyzed using 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The fractions of interest were combined, concentrated to 5 ml and applied on a Superdex 200 16/60 column (GE Healthcare) equilibrated with 20 mM HEPES (pH 7.5), 200 mM NaCl and 2 mM MgCl₂. The selected fractions from the size exclu-sion step were then pooled and concentrated by ultrafiltration to 4.7 mg/ml [Loc1p (1–20)₃], 1.8 mg/ml [Loc1p (1–20)₅] and 1.5 mg/ml (SRRM1).

## Labeling of His<sub>6</sub>-Loc1p-S7C by maleimide-Cy5

The single cysteine mutant His<sub>6</sub>-Loc1p-S7C (Loc1p<sub>S7C</sub>) was purified as described for the wild-type protein (see earlier) and site-specifically labeled using Cy5-maleimide monoreac-tive dye (Cytiva). Prior to labeling, 1 mg purified Loc1p<sub>S7C</sub> was desalted (150 mM NaCl, 10 mM HEPES, pH 7.2), flushed with gaseous N<sub>2</sub> and incubated for 30 min at 20°C. A 100-fold molar excess of tris(2-carboxyethyl)phosphine (TCEP) was added, flushed with N<sub>2</sub> and incubated for another 10 min at 20°C. Cy5-maleimide was dissolved in 50 µl N<sub>2</sub>,N-dimethylformamide, mixed with the protein solution and flushed with N<sub>2</sub> again. The labeling reaction was incubated at 20°C for 2 h and at 4°C overnight. The reaction was stopped by the addition of 5 mM DTT and labeled protein was sepa-rated from free dye by means of gel filtration (Superdex 200 16/60) in 150 mM NaCl, 10 mM HEPES (pH 7.2) and 1 mM DTT. Fractions containing labeled protein were pooled, con-centrated to 2.2 mg/ml, frozen in liquid nitrogen and stored at −80°C.

## Identification of Loc1p-associated RNAs with DNA microarrays

C-terminally TAP-tagged Loc1p was purified from 1 l of cells grown in YPD medium as previously described (17,18). Complementary DNA (cDNA) was synthesized from 3 µg of total RNA derived from the extract and 500 ng of affinity-isolated RNA and labeled with Cy3 and Cy5 fluorescent dyes, respectively. Samples were mixed and hybridized to cDNA microarrays (17,18) and data were submitted to the Stanford Microarray Database (19). Normalized log₂ median ratios from three independent Loc1p affinity isolations and four mock control isolations were filtered for regression correlation of >0.6 and signal over background >1.8 in the channel measuring total RNA, and only features that met this criterion in >60% of the arrays were considered (total 6726 features). Data were exported into Microsoft Excel (Supplementary Tables S2 and S3) for further analysis. Microarray data are available for download via the PUMA database (http://puma.princeton.edu), experiment set no. 7342. Significance analysis of mi-

croarrays (SAM) was performed as described (18) in RStudio, and overrepresented Gene Ontology (GO) terms among protein-coding genes were identified with WebGestalt (20).

## RNA and DNA production

All RNAs and DNAs were ordered from IBA, Biomers or Eurofins, respectively. EAR1 and ASH1 E3 RNAs were *in vitro* transcribed using the MEGAshortscript T7 transcription kit from Life Technologies. The sequences of all oligonucleotides used in this study are listed in Supplementary Table S4.

## Electrophoretic mobility shift assays

Electrophoretic mobility shift assays (EMSAs) were performed as previously described (6,21). Briefly, in a total volume of 20 µl, the indicated protein amount was incubated with 5 nM radioactively labeled RNA and 100 µg/ml competitor yeast transfer RNA (tRNA) in HNMD buffer (20 mM HEPES, pH 7.8, 200 mM NaCl, 2 mM MgCl₂, 2 mM DTT) supplemented with 4% glycerol. For competitive EMSA experiments, 10-, 100- and 500-fold molar excess of the indicated unlabeled RNA was added and yeast tRNA was omitted. Samples were incubated for 25 min at 25°C before RNA-protein complexes were resolved by native 6% Tris/borate/EDTA (TBE) PAGE. Gels were fixed for 15 min in fixing solution [10% (v/v) acetic acid, 30% (v/v) methanol] before vacuum drying. Gels were analyzed using radiograph films. For each EMSA, at least three independent experiments were performed ($n \ge 3$).

## Yeast growth assay

YPD pre-cultures of wild-type (MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0) and *loc1Δ* yeast strains (MATa, ade21, can1100, his311,15, leu23,112, trp11, ura3, GAL, psi+, loc1::natNT2) were inoculated from YPAD agar plates and grown for 24 h at 30°C and 180 rpm. Main cultures were started at a calculated OD<sub>600</sub> of 0.05 in 70 ml YPAD media and grown at 30°C and 180 rpm. Every hour, OD<sub>600</sub> was measured (undiluted at OD<sub>600</sub> 0–0.5 and 1:5 diluted at OD<sub>600</sub> ≥ 0.5). Data points collected over 10 h were plotted and fitted to an exponential growth curve for wild type and *Δloc1* individually, which was used to calculate doubling times ($T_d$ = tau) from three independent experiments.

## Purification of yeast ribosomes

All ribosome purification steps were performed at 4°C, unless stated otherwise. Wild-type yeast cells (S288c) and *loc1Δ* cells were cultured until reaching an OD<sub>600</sub> of 1.5–2.5, washed with water and 1% KCl (w/v), and resuspended in buffer (100 mM Tris, pH 8, 10 mM DTT). After 15-min incubation at room temperature (RT), the cells were pelleted and resuspended in lysis buffer [20 mM HEPES, pH 7.5, 100 mM KOAc, 7.5 mM Mg(OAc)₂, 125 mM sucrose, 1 mM DTT, 0.5 mM PMSF, EDTA-free cOMPlete protease inhibitors (Roche)]. Cells were disrupted in a microfluidizer (three times; 20 000 psi) and centrifuged for 15 min at 15 500 rpm (SS34 rotor). The supernatant was again centrifuged for 30 min at 37 000 rpm (Ti 70 rotor) and only the clear fraction (S100) was further purified. Subsequently, 15 ml S100 was layered over 4 ml of 2 M sucrose cushion and 4 ml of 1.5 M sucrose cushion [sucrose cushion buffer: 1.5 or 2 M sucrose, 20 mM HEPES, pH 7.5, 500 mM KOAc, 5 mM Mg(OAc)₂, 1 mM DTT, 0.5 mM
PMSF] and centrifuged in a Ti 70 rotor tube for 18 h at 53 250 rpm. The ribosome pellet was resuspended in 500 µl water. Experiments were performed at least twice (n ≥ 2).

## Purification of *Mycobacterium smegmatis* ribosomes

All purification steps were performed at 4°C, unless stated otherwise. *Mycobacterium smegmatis* was cultured at 37°C until an OD₆₀₀ of 0.3-0.8 was reached. The cells were harvested by 15-min centrifugation at 5000 × g and resuspended in 70S HB buffer (20 mM Tris, pH 7.4, 100 mM NH₄Cl, 10 mM MgCl₂, 3 mM β-mercaptoethanol). The cell suspension was supplemented with 2 units of DNase I per gram of cell mass and cells were disrupted using a microfluidizer at 10 000-16 000 psi three to five times. The lysate was cleared two times by centrifugation (30 000 × g, 30 min). NH₄Cl and β-mercaptoethanol were added to reach a final concentration of 350 and 7 mM, respectively. The lysate was centrifuged again (Ti 70 rotor, 36 600 rpm, 15 min) and 15 ml of the clear fraction were loaded onto 9 ml of sucrose cushion (20 mM Tris, pH 7.4, 350 mM NH₄Cl, 10 mM MgCl₂, 3 mM β-mercaptoethanol, 1.1 M sucrose). The ribosomes were pelleted using ultracentrifugation (Ti 70 rotor, 36 600 rpm, 17 h), carefully washed three times with 70S buffer (20 mM HEPES, pH 7.4, 60 mM NH₄Cl, 6 mM MgCl₂, 3 mM β-mercaptoethanol) and dissolved in 70S buffer by gentle shaking. After short centrifugation, ribosomes were loaded onto 10-40% sucrose gradients in 70S buffer and ultracentrifuged (SW 28 rotor, 16 800 rpm, 16 h). Fractions containing 70S ribosomes were pooled and pelleted by ultracentrifugation (Ti 70 rotor, 36 600 rpm, 5 h) and dissolved in 70S buffer by gentle shaking.

### Ribosome binding assay—S. cerevisiae

For ribosome binding assays, 1 pmol of ribosomes were incubated with 20 pmol His₆-Loc1p in a total volume of 25 µl in binding buffer [20 mM HEPES, pH 7.5, 150 mM KOAc, 10 mM Mg(OAc)₂, 1 mM DTT] for 15 min at RT and 10 min at 4°C. The binding reaction was loaded onto 625 µl of 0.75 M sucrose in binding buffer and ultracentrifuged in a Ti 55 rotor for 2.5 h at 39 000 rpm. The tube was flash frozen in liquid nitrogen. The sample was divided into two parts (supernatant and pellet) that were trichloroacetic acid (TCA) precipitated and analyzed by 13% SDS-PAGE stained by Sypro Orange (Sigma-Aldrich). Experiments were performed at least twice (n ≥ 2).

### Ribosome binding assay—M. smegmatis

For ribosome binding assays, 130 nM ribosomes were incubated with 1.3 µM His₆-Loc1p in a total volume of 29 µl in binding buffer (20 mM HEPES, pH 7.4, 200 mM NH₄Cl, 6 mM MgCl₂, 3 mM β-mercaptoethanol) for 15 min at RT and 10 min at 4°C. The binding reaction was loaded onto 600 µl of 0.75 M sucrose in binding buffer and ultracentrifuged for 225 min at 33 000 rpm in an SW 55 rotor. The tubes were flash frozen in liquid nitrogen. The sample was divided into two parts (supernatant and pellet) that were TCA precipitated and analyzed by 15% SDS-PAGE stained with Sypro Orange. Experiments were performed at least twice (n ≥ 2).

## Purification of yeast tRNA

Wild-type (S288c) cells were grown in YPD or YPAD media to the early log phase. Cells were harvested (10 min at 4500 rpm), resuspended in buffer [10 mM Mg(OAc)₂, 50 mM NaOAc, 150 mM NaCl, pH adjusted to 4.5) and again harvested (10 min at 4500 rpm) before they were flash frozen in liquid nitrogen. For tRNA purification, cells were resuspended in buffer [10 mM Mg(OAc)₂, 50 mM Tris, pH adjusted to 7.5) and an equal amount of phenol was added. The suspension was incubated for 1 h at 65°C interrupted by vigorous vortexing every 10 min. After centrifugation (10 000 × g, 1 h at 20°C), an equal volume of phenol was added to the supernatant. Subsequently, the mixture was vortexed and again centrifuged (10 000 × g, 30 min at 20°C). The supernatant was precipitated with 0.1 volume of 5 M NaCl and 2 volumes of 100% ethanol at -20°C overnight. The extracted RNA was resuspended in buffer A (40 mM Na₂HPO₄, pH 7) and bound to a MonoQ anion-exchange column. A gradient to 100% buffer B (40 mM Na₂HPO₄, pH 7, 1 M NaCl) was applied and fractions containing pure tRNAs, as assessed by denaturing PAGE, were pooled and precipitated.

## Fluorescence-based chaperone assays using molecular beacons

Fluorescence-based chaperone assays were carried out as previously described (22). In brief, assays were performed using an initial RNA concentration of 100 nM and a concentration of 75 nM of the complementary, unlabeled RNA in a total volume of 900 µl using a FluoroMax-P fluorometer (Horiba). MBP-Loc1p and MBP were added accordingly. Curve analysis was performed using Origin 8.4. Fluorescein (FAM) fluorescence was excited at 495 nm with a slit size of 2 nm. Emission was recorded at 517 nm with a slit size of 3 nm and an integration time of 0.5 s. Experiments were performed at least three times for quantification.

## HIV-TAR annealing assay

TAR annealing assay was essentially performed as previously described (23). Briefly, 0.03 pmol radioactively labeled TAR(+) DNA and equal amounts of cold TAR(−) DNA were incubated with the indicated protein concentrations for 5 min at 37°C in annealing buffer (20 mM HEPES, pH 7.8, 50 mM NaCl, 2 mM MgCl₂). A sample with buffer instead of protein served as a negative control, whereas an incubation at 70°C without protein served as a positive control. The reaction was stopped by the addition of 5 µl stop solution containing 20% glycerol, 20 mM EDTA (pH 8), 2% SDS, 0.25% bromophenol blue and 0.4 mg/ml yeast tRNA. Annealing experiments with Loc1p peptides Loc1p (1-20) and Loc1p (1-20)₂ were treated with 1 µl trypsin (2 mg/ml) for 10 min at RT before the reaction was stopped. Formation of dsTAR DNA was resolved on 8% TBE PAGE at 4°C. Subsequently, gels were fixed, dried and auto-radiographed. Amounts of dsTAR DNA were determined using an LAS phosphorimager reader and ImageJ 1.47v software, and K_m values were calculated from at least three independent experiments.

## NMR experiments

All nuclear magnetic resonance (NMR) experiments were carried out on Bruker Avance III spectrometers at field strengths corresponding to 600 and 800 MHz proton Larmor frequen-
## Sedimentation assay

For sedimentation analysis, total RNA was purified from HeLa cells using TRIzol RNA isolation reagent (Invitrogen). Proteins (50 µM) dissolved in HNM buffer (20 mM HEPES, 200 mM NaCl, 2 mM MgCl₂) were further diluted in low-salt buffer of 50 mM HEPES (pH 7.5) and 50 mM NaCl together with the RNA. The protein, in final concentration of 1 µM, and the RNA, in increasing concentrations (1–16 µg/ml), were incubated at 4°C for 15 min. The samples were centrifuged at 16 100 × g and 4°C for 1 h. The precipitate was resuspended in the same buffer with equal volume as the supernatant. Equal volumes of the pellet fraction and the supernatant were analyzed by SDS-PAGE and stained by SyproRuby. Experiments were performed at least two independent times.

## In vitro phase separation assays

Purified proteins were diluted in condensate buffer (20 mM Na₂HPO₄/NaH₂PO₄, pH 7.5, 150 mM NaCl, 2.5% glycerol, 1 mM DTT) to the indicated final concentrations and total HeLa cell RNA was added at the indicated RNA-to-protein mass ratios. Experimental conditions for microscopic phase separation assays underwent some evolution during the project.

Initially, samples were directly transferred to self-assembled sample chambers formed by double-sided sticky tape, taped onto an untreated glass slide and sealed with a coverslip to visualize condensates. Imaging was done by phase contrast microscopy using a 63×/1.40 Oil/Ph3 objective on an AxioCam (Zeiss, Oberkochen, Germany). For optimized experiments with round condensates, coverslips and glass slides were pretreated with the following procedure. They were washed with purified ddH₂O, followed by a 30-min incubation in 2% Hellmanex III. After washing three times with purified ddH₂O, glass slides and coverslips were incubated in 1 M NaOH for 30 min, washed three times with purified ddH₂O and dried in a gaseous N₂ stream. Condensates were imaged by phase contrast microscopy using an HC PL Fluotar L 40×/0.6 PH2 objective on a Leica DMi8 (Leica, Germany). Experiments were performed at least three independent times.

## Droplet fusion analysis

Droplet fusion was recorded in mixtures containing 20 µM Loc1p and 0.5× mass ratio of total HeLa RNA with the above-mentioned setup (HC PL Fluotar L 40×/0.6 PH2 objective on Leica DMi8) in movie mode. Fusion events were manually located and the aspect ratio of droplets measured in ImageJ was plotted against time. The resulting data were fitted to an exponential decay model in OriginPro 9.65. Three different fusion events were inspected.

## FRAP experiments

Fluorescence recovery after photobleaching (FRAP) was used to measure the dynamic exchange of proteins between the droplets and the surrounding protein solution using an HC PL APO 40×/1.3 OIL CS2 objective mounted on a Leica TCS SP8 inverse confocal microscope (Leica, Germany). At 40× magnification and 16× optical zoom, droplets were outlined with a circular ‘bleaching’ overlay object. FRAP parameters were as follows: three to four pre-bleaching images were recorded, bleaching was done at a laser power of 100% for 1 s (HeNe laser 633 nm) and movies were recorded at a frame rate

of 1.95 s/frame. An immediate post-bleach image and several images over a total time range of 83 s were recorded. FRAP curves were calculated by normalizing the fluorescence signal to the background and the pre-bleach intensity. All imaging was done with the same acquisition settings (image size 512 × 512, emission wavelength 641–740 nm, scan speed 400 Hz, gain 573). FRAP experiments were repeated five times.

## Crystallization, diffraction data collection and processing

The crystallization experiments for the RNA (3'-UCUCUGGUUAGGAAACUAACUAGGGA-5') were performed at the X-ray Crystallography Platform at Helmholtz Zentrum München. The initial crystallization screening was done at 292 K with a Mosquito (SPT Labtech) nanodrop dispenser in sitting-drop 96-well plates and commercial screens. After selecting the best hits from the screening, manual optimization was performed. The best crystals grew in 100 mM NaCl, 15 mM BaCl₂, 40 mM sodium cacodylate (pH 7.0), 44% (v/v) 2-methyl-2,4-pentanediol (MPD) and 12 mM spermine tetrahydrochloride. For the X-ray diffraction experiments, the crystals were mounted in a Nylon fiber loop and flash cooled to 100 K in liquid nitrogen. Diffraction data were collected on the SLS PXIII X06DA beamline (PSI, Villigen) and the measurements were performed at 100 K. X-ray diffraction dataset for RNA was collected to 2.0 Å resolution (Supplementary Table S5). The dataset was indexed and integrated using XDS (39) and scaled using SCALA (40,41). Intensities were converted to structure factor amplitudes using the program TRUNCATE (42). Supplementary Table S5 summarizes data collection and processing statistics.

## Structure determination and refinement

The structure of RNA was solved using the single-wavelength anomalous dispersion (SAD) phasing with barium from the mother liquor, using the Auto-Rickshaw, the EMBL-Hamburg automated crystal structure determination platform (43,44). The input diffraction data were prepared and converted for use in Auto-Rickshaw using programs of the CCP4 suite (41,45). F; values were calculated using the program SHELXC (46). Ten heavy atom positions were located with the program SHELXD (46). The correct hand for the sub-structure was determined using the programs ABS (47) and SHELXE (46). The occupancy of all substructure atoms was refined using the program MLPHARE (41) and phases improved by density modification using the program DM (41,48). The initial model was partially built using the program ARP/wARP (49,50). Further model building and refinement was performed with COOT (51) and REFMAC5 (52), respectively, using the maximum-likelihood target function including TLS parameters (53). The final model is characterized by *R* and *R*<sub>free</sub> factors of 17.5% and 24.1%, respectively (Supplementary Table S5). The stereochemical analysis of the final model was done in MolProbity (54). All crystallographic software was used from the SBGRID software bundle. Atomic coordinates and structure factors have been deposited in the Protein Data Bank under accession code 6YMC.

## Small-angle X-ray scattering

Synchrotron small-angle X-ray scattering (SAXS) data were collected at beamline ID14-3 (ESRF, Grenoble, France) with a wavelength of 0.931 Å. His₆-Loc1p was measured at three
different concentrations (3, 5 and 10 mg/ml) in a buffer con-
taining 200 mM NH₄Cl, 20 mM HEPES (pH 7.5), 6 mM
MgCl₂ and 5 mM DTT, with exposure times of 30 s each.
Evaluation and processing were performed using programs
from the ATSAS 2.1 software package (55). PRIMUS was used
for primary data analysis and to exclude potential sample ag-
gregation during the measurement. Based on Guinier plots,
very similar radii of gyration (R₉) between 4.6 and 4.8 nm
were calculated for the three different Loc1p concentrations.
Buffer-corrected profiles of low, medium and high Loc1p con-
centrations were used to calculate individual Kratky plots. As
a reference, bovine serum albumin (5.7 mg/ml) was measured
in a buffer containing 50 mM HEPES (pH 7.5) and 2 mM
DTT.

Reagents

Commercially available enzymes thrombin (112374, Sigma-
Aldrich), DNase I (A3778, AppliChem) and trypsin (T8003,
Sigma-Aldrich) were purchased. The peptides for the peptide
tiling array were purchased from JPT Peptide Technologies.
The PureLink RNAMini Kit (12183020, Thermo Fisher) was
used for the isolation of total HeLa RNA.

Biological resources

*Escherichia coli* strains BL21 (DE3) Star, ER2566 and BL21-
Gold (DE3) pRARE were used for protein expression (see de-
tails below). HeLa cells were used for total RNA isolation.
*Saccharomyces cerevisiae* wild-type (MATa, his3Δ1, leu2Δ0,
met15Δ0, ura3Δ0) and *loc1Δ* (MATa, ade21, can1100,
his311,15, leu23,112, trp11, ura3, GAL, psi+, loc1::natNT2)
strains were used.

Statistical analyses

Information on the respective statistical method and corre-
sponding sample sizes are given in the figure legends and the
corresponding methods section.

Novel programs, software and algorithms

The code for the computational analyses is available at https://doi.org/10.5281/zenodo.13348876.

Web sites/database referencing (microarray data)

http://puma.princeton.edu/: experiment set no. 7342; https://
www.ncbi.nlm.nih.gov/geo/: experiment set no. GSE273374.

Results

loc1Δ cells show growth defects and depletion of
ribosomes

In order to dissect the function of Loc1p, we first compared the
growth rate of a *loc1Δ* strain in suspension culture with that
of a wild-type *S. cerevisiae* culture. For the *loc1Δ* strain, we
observed a 2-fold increased doubling time compared to wild-
type cells (Figure 1A). This finding is consistent with previ-
ously reported ribosome profiles showing that 80S ribosomes,
half-mer ribosomes and 60S ribosomal particles are less abun-
dant in *loc1Δ* cells compared to wild type (4,14). Consider-
ing the central importance of ribosomes for cellular functions,
these data suggest that the reduced amount of ribosomes is
responsible for the observed slow-growth phenotype of the
*loc1Δ* strain.

Loc1p associates with rRNAs of the large ribosomal
subunit

In order to assess the cellular binding targets of Loc1p, we im-
munoprecipitated TAP-tagged Loc1p expressed in yeast under
the endogenous promoter and identified the co-purified RNAs
by cDNA microarrays. Among the co-purified RNAs, the class
of rRNAs was highly enriched (Supplementary Figure S1A
and Supplementary Tables S2 and S3), suggesting that this nu-
cleolar RNA-binding protein preferentially binds to rRNAs.
In addition, open reading frames located in proximity of
rDNA fragments were among the most abundant Loc1p tar-
gets. Together with the previously reported defects in early
rRNA processing in *loc1Δ* cells and the nucleolar localiza-
tion of Loc1p (15), these data strongly suggest a direct role
of Loc1p in early rRNA processing. Nevertheless, Loc1p was
also associated with mRNAs (379 protein-coding genes at 1%
false discovery rate), a significant fraction of them coding for
membrane proteins (*P*-value <10<sup>-8</sup>; 150 out of 297 mem-
brane protein genes).

In order to assess whether Loc1p directly and specifically
associates with mature ribosomes, we performed ultracen-
trifugation using purified *M. smegmatis* or *S. cerevisiae* ribo-
somes and recombinant His₆-Loc1p. When centrifuged sepa-
rately, ribosomes sedimented in the pellet and the majority of
Loc1p remained in the supernatant. However, when recombi-
nant His₆-Loc1p was mixed with ribosomes, Loc1p became
enriched in the pellet (Figure 1B and C), indicating a direct
interaction between Loc1p and assembled ribosomes. The in-
teraction with both pro- and eukaryotic ribosomes suggests
unspecific binding to rRNA or ribosomal proteins and a rather
general mode of ribosome association.

Loc1p is an unspecific nucleic acid binding protein

In order to systematically assess the specificity of Loc1p for its
target RNAs, we performed EMSAs with radioactively labeled
RNAs. Loc1p bound with similar affinities to its previously
reported RNA target sites in the ASH1 and EAR1 mRNAs
(38,56), to the HIV-TAR control RNA and even to poly-A
RNA (Figure 1D). Binding to the E3 element of the ASH1
RNA could be competed for by an excess of unlabeled ASH1,
HIV-TAR or poly-A RNAs, but not by the EAR1 RNA (Figure
1E). Also, Loc1p binding to the HIV-TAR RNA was success-
fully competed for by unlabeled ASH1, HIV-TAR, poly-A and
EAR1 RNAs (Figure 1F). In summary, we observe unspecific
RNA binding by Loc1p that exhibits only minor differences
in binding affinities in competition experiments.

In order to find out whether Loc1p preferentially binds to
single-stranded (ss) or double-stranded (ds) DNA or RNA,
we performed EMSAs with DNA and RNA. In a first con-
trol experiment, mobility shifts by Loc1p were observed
for both ssRNA and ssDNA with similar binding affinities
(Supplementary Figure S1B and C). Next, we performed EM-
SAs with in-gel FRET to compare Loc1p binding to dsRNA
and to an RNA-DNA hybrid. In-gel FRET analysis after na-
tive PAGE confirmed binding and showed that both strands
remained hybridized upon Loc1p binding (Supplementary
Figure S1D and E). In summary, we conclude that Loc1p binds
indiscriminately to ssRNA, ssDNA, dsRNA and DNA-RNA
hybrids. Together with the observed lack of sequence prefer-
ence (Figure 1D–F), these findings show that Loc1p interacts
with general features of nucleic acids, such as their phosphate-
ribose backbone.
<figure><img src="image_4.png" /><figcaption>**Figure 1.** Loc1p binds directly to ribosomes and unspecifically to RNA. (A) Comparison of doubling time of wild-type (S288C) and *loc1Δ* strains. *loc1Δ* cells show a severe growth delay (n = 3). Analytical ultracentrifugation of *S. cerevisiae* (B) and *M. smegmatis* (C) ribosomes and His₆-tagged Loc1p reveals a co-enrichment of Loc1p with ribosomes in the pellet. In the absence of ribosomes, Loc1p is mainly found in the supernatant fraction of the sucrose cushion. (D) EMSAs with Loc1p and radioactively labeled *ASH1* E3 localization element (LE), *EAR1* LE, *HIV-TAR* stem-loop and poly-A₆₀ RNA reveal unspecific binding in the nanomolar range. (E, F) Competition EMSAs with 100 nM MBP-Loc1p, 5 nM radioactively labeled RNA, and 10-, 100- and 500-fold excess of cold competitor RNA. Experiments show that *ASH1* E3, *TAR-57* and poly-A₆₀ can compete for Loc1p interaction with *ASH1* E3 (E) or *TAR-57* (F).</figcaption></figure>

## Loc1p acts as RNA-folding catalyst

How could the observed unspecific RNA binding be important for ribosome biogenesis? An intriguing possibility is that binding of Loc1p to RNA influences its conformation and folding required for proper RNP biogenesis in the RNA-crowded nucleolus. To assess this possibility, we performed *in vitro* RNA chaperone experiments with a 27-base stem-loop labeled at its 5'-end with a fluorescent dye and at its 3'-end with a quencher molecule (22,57). Separation of annealed strands results in less quenching and thus higher fluorescence intensity. When increasing amounts of Loc1p were titrated to this RNA stem-loop, no significant increase in fluorescent signal was observed (Figure 2A), even at concentrations several fold higher than required for efficient dsRNA binding (Figure 1D). From this, we conclude that Loc1p does not melt dsRNA.

In contrast, when an ssRNA oligonucleotide that fails to form stable double strands was used, the addition of Loc1p resulted in a concentration-dependent quenching of the fluorescence (Figure 2B). This indicated that Loc1p brings 5' and

3' ends of the ssRNA in closer proximity. Finally, we tested the ability of Loc1p to promote or inhibit the transition from an intermediate state of RNA folding to a more stable, energetically favored fold. For this, we used the above-described stem-loop RNA (Figure 2A) and added unlabeled, fully complementary RNA (Figure 2C, left panel). Since the unlabeled, complementary oligonucleotide hybridizes over its entire length with the hairpin sequence, the double-stranded heterodimer should be the energetically preferred folding state. However, to reach this state the energetic barrier of melting the intramolecular stem interactions has to be overcome. In the absence of protein or the presence of MBP containing numerous positive surface charges, this transition occurred at a rather slow rate. In contrast, in the presence of Loc1p we observed an ~7-fold increased reaction rate toward the formation of the energetically favored dsRNA (Figure 2C, right panel). Thus, similarly to a catalytic reaction, Loc1p accelerates the transition of folded RNAs toward their thermodynamically most favored state.
<figure><img src="image_5.png" /><figcaption>B</figcaption></figure>

<figure><img src="image_6.png" /><figcaption>C</figcaption></figure>

<figure><img src="image_7.png" /></figure>

<figure><img src="image_8.png" /><figcaption>D</figcaption></figure>

<figure><img src="image_9.png" /></figure>

**Figure 2.** Loc1p induces conformational changes in nucleic acids. (A) Fluorescence intensity of a stem–loop molecular beacon (MB-D16) is not changed upon titration with MBP-Loc1p, indicating that Loc1p is unable to change the secondary structure of this RNA. (B) Fluorescence intensity of a single-stranded molecular beacon (MB-A5) is decreased upon titration of Loc1p, indicating the induction of conformational changes. (C) In the presence of antisense RNA (anti-MB-D16), titration of Loc1p changes the fluorescence intensity of the stem–loop shown in panel (A). This suggests that Loc1p promotes the formation of the energetically favored structure. Left: For steady-state experiments, the molecular beacon was pre-incubated with antisense RNA before Loc1p was added. Right: In time-course experiments, Loc1p, MBP or buffer alone was pre-incubated with the molecular beacon prior to addition of antisense RNA. Addition of 1 µM Loc1p increases the reaction rate ~7-fold, suggesting that Loc1p promotes the formation of the energetically most favored state. (D) Comparative TAR annealing assay showing that MBP-Loc1p and Imp4p promote annealing of dsDNA while Hfq displaces dsTAR DNA under these experimental conditions. Radioactively labeled TAR(+) DNA was incubated with TAR(−) DNA at 37°C and with MBP-Loc1p, SUMO-Hfq, SUMO-Imp4p or buffer (negative control, 37°C). As a positive control, the sample was incubated at 70°C for heat-induced annealing. While 5 nM of MBP-Loc1p is sufficient for complete annealing, Imp4p requires >3 µM to reach a comparable activity. All experiments were performed independently at least three times.
## Comparison of Loc1p with other RNA-folding catalysts

In order to compare the activity of Loc1p as folding catalyst with previously reported RNA chaperones, we performed comparative annealing assays with Loc1p, Imp4p and Hfq. Imp4p is an RNA chaperone required in the early biogenesis of eukaryotic ribosomes (58,59). Hfq is a bacterial protein capable of RNA annealing or strand displacement, depending on the specific experimental condition (60).

For comparison of catalytic activities, we used a previously described *HIV-TAR* annealing assay (23). Radioactively labeled *TAR* plus strand (*TAR+*) and unlabeled minus strand (*TAR−*) DNA were incubated with the different proteins at 37°C and the formation of double strands was assessed by native PAGE. In this assay, Loc1p showed by far the strongest annealing activity of all tested chaperones (Figure 2D). Already 5 nM of Loc1p was sufficient to completely anneal *TAR+* and *TAR−* DNA strands. Imp4p also annealed these oligonucleotides, but a protein concentration of >3 µM was necessary for complete annealing. A similar amount of Hfq had to be used to induce a complete strand separation in this assay. Thus, under these experimental conditions, Loc1p was the most potent nucleic acid annealing catalyst among the tested chaperones. These findings further support our observations from Figure 2B and C.

## Loc1p lacks recognizable domain folds and remains unfolded upon RNA binding

Although Loc1p is a potent RNA binder, it lacks any recognizable similarity to known RNA-binding domains. The Kratky plot of SAXS data of Loc1p at different concentrations showed that it is intrinsically disordered and lacks a globular fold (Figure 3A). For a more detailed assessment, we performed solution NMR experiments with ¹H–¹⁵N correlation spectra of ¹⁵N-labeled Loc1p (Figure 3B). The spectrum showed poor signal dispersion, confirming that Loc1p is largely unstructured in the absence of a binding partner.

In order to assess whether RNA binding induces folding of Loc1p, we titrated different RNAs to Loc1p and monitored NMR spectral changes. Addition of either a 16-nt *HIV-TAR* stem-loop RNA or a confirmed target of Loc1p, the 49-nt E3 stem-loop of the *ASH1* RNA, to ¹⁵N-labeled Loc1p yielded chemical shift perturbations to some extent, but no significantly increased spectral dispersion (Figure 3B). Thus, Loc1p remains largely unstructured even when bound to the tested RNAs.

## A repetitive motif found throughout Loc1p mediates RNA binding

To characterize the RNA interaction within the unstructured Loc1p, we performed RNA binding experiments using a tiling array with 20-residue-long peptides of the 204-aa-long Loc1p, each shifted by 3 aa. In these experiments, 50 out of 63 peptides along the entire sequence of Loc1p showed significant binding to a radioactively labeled *ASH1* E3 RNA (Figure 3C and D, and Supplementary Figure S2), indicating the presence of several RNA-binding motifs along the protein sequence.

Analyses of the correlation between peptide sequences of Loc1p and RNA-binding activity (Figure 3C and D, and Supplementary Figures S2 and S3A) identified a defined pattern of positively charged amino acids with short spacers that bound RNA (Figure 3E). The spacers were

characterized by the absence of positively charged residues and the presence of one or more acidic residues. This pattern of alternating motifs and spacers occurred eight times in Loc1p (Supplementary Figure S3). Motif-containing peptides that had no or only a single negatively charged side chain, such as peptides A9, A10, A11, A14, A15, B5, B6, B7, B8 or C15, tended to show the highest binding signal. In contrast, peptides with at least three negatively charged residues, such as A4, A5, A7, A8 or B14–C12, showed on average weak or no binding (Figure 3C and D, and Supplementary Figure S2). Thus, the RNA-binding activity of these repetitive motifs in Loc1p requires positively charged amino acids and tolerates only few negatively charged residues.

## A single RNA-binding motif is sufficient to stabilize dsRNA

In order to understand the molecular details of the function of this RNA-binding motif, we performed structural analyses of the first motif in Loc1p consisting of aa 3–15 [Loc1p (3–15)] and a dsRNA sequence with 11 base pairs fused to a minimal tetraloop (dsRNA tetraloop; Supplementary Figure S4A). The crystal structure of this dsRNA tetraloop alone at 2.0 Å resolution revealed a complete base pairing in the stem region as well as a highly coordinated loop (Figure 4A and Supplementary Table S5).

We applied NMR to characterize the binding between the first motif [Loc1p (3–15)] and the dsRNA tetraloop. The assignment of imino cross-correlation signals of the RNA alone confirmed the hairpin conformation of the dsRNA tetraloop in solution (Supplementary Figure S4A). Next, we titrated Loc1p (3–15) with up to a 22-fold molar excess to the dsRNA tetraloop and recorded 1D spectra of nucleotide imino signals. Increasing concentrations of Loc1p (3–15) induced a continuous signal shift of the G12 imino signal (Figure 4B, left). This indicated a strong interaction of the peptide in this region of the RNA, whereas other signals were only moderately affected. Chemical shifts of the imino signals of the RNA remained largely unchanged upon titration of the peptide, showing that the overall secondary structure of a dsRNA is not altered upon binding. This observation is consistent with the effect of full-length Loc1p in chaperone assays (Figure 2A).

When titrating the peptides Loc1p (22–35) and Loc1p (118–131), which lacked the RNA-binding motifs (Supplementary Figure S3A and C), no NMR chemical shift changes were observed even at 10-fold excess of peptides over RNA. Only very high excess of 15- and 22-fold resulted in larger shifts of the G12 imino signal (Figure 4B, right). Considering the high molar excess with peptide concentrations of up to 2.2 mM, this interaction is significantly weaker and may reflect a more unspecific interaction with these peptides. This interpretation is consistent with results from the tiling array where both peptides failed to bind RNA (peptides A7 and B19 in Figure 3C and D, and Supplementary Figure S2).

## NMR studies confirm that peptide binding stabilizes RNA secondary structures

In order to understand the specific contribution of the peptide motif, we recorded 1D ¹H spectra of RNA imino signals at increasing temperatures in the absence and presence of Loc1p peptides. The normalized signal intensities of respective imino signals were used to generate melting curves (Figure 4C and Supplementary Figure S4C and D). In the pres-
<figure><img src="image_10.png" /><figcaption>**Figure 3.** RNA binding of the intrinsically unstructured Loc1p is mediated by distinct motifs within the Loc1p sequence. (A) Kratky plots of SAXS measurements at three Loc1p concentrations indicate that the protein is largely unfolded. The scattering intensity [as $I(q) \times q^2$] is plotted against the scattering vector $q$. Unfolded/highly flexible proteins are typically characterized by a plateau at higher $q$ values. (B) $^1$H-$^{15}$N-HSQC spectra of Loc1p alone (blue) and in the presence of TAR RNA (red) and the ASH1 E1 RNA (green). Minor signal shifts indicate that the interaction with RNA does not induce a secondary structure fold in large parts of Loc1p. (C) Binding experiments of radioactively labeled ASH1 E3 (short) RNA to a Loc1p peptide array revealed binding of a large portion of the spotted peptides to the RNA. Peptides had a length of 20 aa and an offset of 3 aa. (D) Bar graph depicting RNA binding intensities of each peptide. Signals from the peptide array shown in panel (C) were quantified with ImageJ and normalized against the best binding peptide ($A_{12}$ set to 100%; $n = 1$). Large sequence stretches of Loc1p show binding to ASH1 E3 (short) RNA. (E) The consensus sequence of the PUN motif is characterized by three repetitive units of one to three positively charged residues [[RK](1,3) in green] interspaced by one to three residues that are not positively charged [[RK](1,3) in red]. (F) One-letter-code sequence logo integrating all eight PUN motifs of Loc1p (amino acid chemistry: blue, basic; red, acidic; black, hydrophobic; purple, neutral; green, polar). The amino acid position is plotted against the information content of each position in bits.</figcaption></figure>

ence of the first motif Loc1p (3–15), the melting curves of the imino signals of U3, U5 and G24 were shifted to higher temperatures, indicating a stabilization of the stem–loop. In summary, melting points of imino signals in the 5' and 3' regions and in the loop region were increased (Figure 4D). In contrast, the control peptides Loc1p (22–35) and Loc1p (118–131) led to a decrease in melting points of the majority of imino signals (Figure 4D), indicating destabilization of

the dsRNA. In conclusion, these data indicate that the positively charged RNA-binding motif identified contributes to the stabilization of RNA secondary structures. Of note, titration of high concentrations of each of the three peptides resulted in resonance shifts in 1D $^{31}$P-NMR experiments. However, Loc1p (3–15) induced the strongest chemical shift perturbations (Supplementary Figure S4B), consistent with its interaction with phosphates in the phosphoribose backbone.
<figure><img src="image_11.png" /><figcaption>**Figure 4.** Structure analysis of RNA binding and assessment of annealing activity of PUN motifs. (A) X-ray structure of the dsRNA tetraloop highlighting the coordinated GAAA minimal tetraloop (G12–A15) and the base-paired stem. (B) Titration of the dsRNA with different Loc1p-derived peptides.</figcaption></figure>
To analyze how the RNA interaction affects the confor-
mation of an RNA-binding peptide, we performed NMR ex-
periments with ¹⁵N and ¹³C isotope-labeled Loc1p (3–15).
After side-chain assignment, we performed a titration with
the dsRNA tetraloop and recorded ¹H–¹⁵N-HSQC spectra
(Figure 4E, left). Upon addition of RNA, we observed shifts
of all peptide signals. Analyzing the chemical shift changes
as a function of RNA concentration yielded K<sub>D</sub> values in
the range from 19 to 286 µM (Figure 4E, right). NOESY
of the motif in the absence of RNA showed only few intra-
residual and sequential H<sub>N</sub>–H<sub>α1</sub> cross-signals, indicating that
the peptide is flexible and not structured (Figure 4F, red,
and Supplementary Figure S4E). In the presence of RNA, the
NOESY spectrum contained significantly more signals (Figure
4F, black), with a particular increase of intra-residual signals.
For instance, the methyl group of leucine 12 shows an NOE to
the amide proton of arginine 9, indicating their close proxim-
ity. The increase in signal quantity indicates that amino acid
side chains of the dsRNA-bound motif have less rotational
freedom and hence are more rigid than the free peptide. Analy-
sis of ¹³C secondary chemical shifts (Figure 4F, bottom), how-
ever, clearly showed that the motif does not adopt a defined
secondary structure when bound to the RNA. In summary,
these results indicate that Loc1p (3–15) binds to the dsRNA
tetraloop with a more rigid conformation without a specific
secondary structure.

Because of their functional and structural properties, we
named the RNA-binding elements of Loc1p PUN motifs.

Multiple PUN motifs cooperate for RNA annealing

Since in the tiling array each PUN motif-containing pept-
tide showed RNA binding, a single PUN motif might al-
ready be sufficient for RNA-annealing activity. In order to
test this possibility, we compared the chaperone activity of
wild-type Loc1p (204 aa with eight motifs) with a peptide
bearing only the most N-terminal PUN motif [Loc1p (1-20);
Supplementary Figure S3A and C]. We also used peptides con-
taining 2 [Loc1p (1-20)<sub>2</sub>] or 10 [Loc1p (1-20)<sub>10</sub>] of these N-
terminal PUN motifs. Whereas a single motif [Loc1p (1-20)]

only showed weak annealing activity at the highest concen-
tration of 25 µM (Figure 4G), Loc1p (1–20)<sub>2</sub> already yielded
strongly improved activity (Figure 4G and H). Although no
Michaelis–Menten constant (K<sub>m</sub>) could be derived for Loc1p
(1–20), a comparison of its band intensities with the ones
of Loc1p (1–20)<sub>2</sub> indicated an ~50-fold higher activity for
the latter. Loc1p (1–20)<sub>10</sub> showed again a >50-fold improve-
ment in activity over Loc1p (1–20)<sub>2</sub> (Figure 4G and H). These
findings suggest that the RNA-binding motifs in Loc1p act
cooperatively in nucleic acid annealing. Interestingly, wild-
type Loc1p and Loc1p (1–20)<sub>10</sub> showed comparable activi-
ties in this assay (Figure 4G), suggesting that the concatena-
tion of PUN motifs is sufficient to achieve wild-type annealing
activity.

Multiple PUN motifs undergo phase separation in
the presence of RNA

A number of recent studies demonstrated that phase separa-
tion driven by proteins or protein-nucleic acid complexes is
a prevalent organization principle of macromolecular assem-
blies in cells (61). Phase separation is thought to be the driv-
ing force for establishing functionally distinct membraneless
organelles such as stress granules, processing bodies and even
the nucleolus (62–64). Since Loc1p is located in the nucleolus
and mainly consists of low-complexity regions that could po-
tentially promote phase separation, we tested whether Loc1p
with its PUN motifs is able to undergo RNA-mediated phase
separation. We first mixed increasing amounts of recombi-
nant Loc1p with 0.5× mass ratio of total HeLa cell RNA
and observed formation of microscopically visible conden-
sates at Loc1p concentrations of 5 µM or higher (Figure
5A). The number and size of the condensates were clearly
dependent on the Loc1p concentration, while 30 µM Loc1p
without RNA did not result in phase separation. For fur-
ther studies, we used an improved protocol to obtain con-
densates with perfectly round shapes with typical diame-
ters between 1 and 5 µm (Figure 5B) at a concentration of
20 µM Loc1p and 0.5× mass ratio of RNA. In order to
show that the observed structures were indeed droplet-like

Whereas the titration of Loc1p (3–15) shifts the signal of G12 in a continuous manner, the two peptides lacking the RNA-binding motif Loc1p (118–131) and Loc1p (22–35) do not bind until very high, 15-fold excess, where peaks start to display sudden large shifts. (C) Temperature dependence of imino NMR signals of unbound dsRNA and dsRNA bound to different Loc1p-derived peptides at the highest molar excess (22:1) shown in panel (B). The decrease of imino signal intensities (shown: U3, U5, G6, G24) was used to determine the stabilizing effect of the three different peptides titrated in panel (B) in temperature scans. Whereas Loc1p (3–15) (blue dots) has a stabilizing effect on the hairpin RNA (free RNA: red dots), the control peptides Loc1p (118–131) (green dots) and Loc1p (22–35) (purple dots) have an overall destabilizing effect. The only exception is a slight stabilizing effect for U3 by Loc1p (118–131). (D) Heat map illustrating the temperature-dependent stabilization of the end of the stem upon peptide binding. In contrast, Loc1p (118–131) and especially Loc1p (22–35) destabilize the ends of the stem and the loop regions. Loc1p (22–35) has even a destabilizing effect on the central stem region. The estimated melting temperatures for the four most affected base pairs are given in the table below. (E) ¹H,¹⁵N-HSQC spectrum showing the titration of dsRNA to ¹⁵N,¹³C-labeled Loc1p peptide. Saturation is reached at a 3–4-fold excess of dsRNA tetraloop. To the right, three examples are shown of fitted binding curves from chemical shift perturbations. (F) 2D NOESY spectra overlay of unbound Loc1p peptide (red) and dsRNA-bound Loc1p (black). In the free state, the Loc1p peptide is flexible, as only intra-residual and sequential H<sub>N</sub>–H<sub>α1</sub> NOE cross-peaks are observed. Upon binding to dsRNA, additional NOEs can be observed, especially nonsequential and inter-residual NOEs. The dashed lines indicate strips from the H<sub>N</sub> region of indicated residues to other protons. The purple circle indicates the strong overlap of positively charged residues (K4, K5, K8, R14), which prevents full assignment of peptide side chains. Secondary chemical shifts (below the spectrum) clearly show that no secondary structure is formed upon RNA binding. (G) TAR annealing assay with radioactively labeled TAR(+) and unlabeled minus strand demonstrates that concatenation of the most N-terminal Loc1p motif is sufficient to mimic the annealing activity of wild-type Loc1p *in vitro*. Both strands were incubated with increasing concentrations of wild-type Loc1p, Loc1p (1–20)<sub>10</sub>, Loc1p (1–20)<sub>2</sub>, Loc1p (1–20) or buffer (negative control: NC) at 37°C. Heat-induced displacement at 70°C and in the absence of Loc1p served as a positive control (PC). Formation of ds TAR was analyzed by 8% native TBE PAGE. Wild-type Loc1p has an annealing activity comparable to an artificial protein bearing 10 Loc1p motifs [Loc1p (1–20)<sub>10</sub>]. (H) Comparison of annealing activities of sequences bearing 1, 2 and 10 Loc1p motifs. For Loc1p (1–20), annealing activity was not determined because even with 50 µM no saturation was reached. According to the intensities of annealed ds TAR, Loc1p (1–20)<sub>2</sub> showed an estimated 50–100-fold higher activity than Loc1p (1–20). Furthermore Loc1p (1–20)<sub>10</sub> showed an over 50-fold higher annealing activity than Loc1p (1–20)<sub>2</sub>. Since wild-type Loc1p showed even better reactivity that exceeded the limits of this assay, no K<sub>m</sub> could be derived. Shown are quantifications from three independent experiments.
<figure><img src="image_12.png" /><figcaption>**Figure 5.** Loc1p or multiple copies of its N-terminal PUN motif form condensates with RNA. (A–G) The formation of condensates was assessed by phase contrast and fluorescence microscopy. (A) At a protein:RNA mass ratio of 0.5, phase separation was observed already at 5 µM Loc1p. (B) At the same protein:RNA ratio and 20 µM Loc1p, condensates had a size of 1–5 µm and showed round shapes. (C) The observed condensates fuse and round up after fusion, confirming their liquid-to-gel-like properties. (D) Like unlabeled Loc1p, Cy5-labeled Loc1p<sub>ps7c</sub> promotes RNA-dependent droplet formation and partitions into the droplets. (E) Fluorescence of Cy5-Loc1p<sub>ps7c</sub>/RNA droplets recovers after photobleaching to 20–30% in FRAP experiments. (F, G) Loc1p (1–20)<sub>10</sub> formed condensates already at 2.5 µM and an RNA:protein mass ratio of 0.025 and larger condensates with increasing RNA concentration. No phase separation was observed in the absence of RNA. (H) RNA-dependent phase separation of Loc1p and Loc1p (1–20)<sub>10</sub> was confirmed by sedimentation experiments followed by SDS–PAGE stained with SyproRuby. Experiments were repeated at least once (n ≥ 2).</figcaption></figure>
condensates and not protein-RNA precipitates, we analyzed
individual droplet fusion events. Although relatively slow,
condensates clearly fused and relaxed into spherical shapes
after fusion (Figure 5C and Supplementary Movie S1). To di-
rectly demonstrate the presence of Loc1p in these conden-
sates, we introduced a single cysteine (Loc1pS7C) and labeled
the protein using Cy5-maleimide (Cy5-Loc1pS7C). RNA/Cy5-
Loc1pS7C droplets showed strong fluorescence under the same
conditions as wild-type Loc1p, indicating that Cy5-Loc1pS7C
indeed partitions into the droplets (Figure 5D). In addition,
FRAP experiments were performed to assess the dynamics of
Loc1p in these droplets. Fluorescence of Cy5-Loc1pS7C/RNA
condensates recovered after photobleaching on average to
20-30% after 30 s (Figure 5E and Supplementary Movie
S2), demonstrating a dynamic exchange of Loc1p between
the droplets and the surrounding protein solution. Both the
droplet fusion and the fluorescence recovery to around 20-
30% are in line with the assumption that the observed con-
densates have liquid-like to gel-like properties.

As we had observed that a peptide sequence with 10 consecutive PUN motifs showed high RNA chaperone activity (Figure 4G), we next tested whether Loc1p (1–20)₁₀ was also able to trigger RNA-mediated phase separation. Indeed, Loc1p (1–20)₁₀ formed visible condensates already at a concentration of 2.5 µM protein and a mass ratio of 0.025 × RNA (Figure 5F). We further confirmed the robustness of the apparent PUN motif-mediated phase separation by providing a constant concentration of Loc1p (1–20)₁₀ and increasing ratios of RNA (Figure 5G). In all cases, RNA-dependent phase separation was observed. In order to test these findings with an independent assay, RNA-driven phase separation of Loc1p and Loc1p (1–20)₁₀ was further confirmed by centrifugation sedimentation experiments (Figure 5H). Since cooperative effects of multiple PUN motifs were observed in RNA chaperone assays (Figure 4G and H), we compared phase separation of Loc1p (1–20)₃ or Loc1p (1–20)₅ and RNA. Indeed, a clear correlation between the number of PUN motifs per peptide chain and their ability to mediate phase separation was observed (Supplementary Figure S5).

To assess whether Loc1p also mediates RNA annealing and
RNA-dependent phase separation on a physiological target,
we performed corresponding experiments with the E3 local-
ization element of ASH1 mRNA. This transcript is bound co-
transcriptionally by Loc1p and shuttles together through the
nucleolus (7,8,15). Notably, formation of liquid-liquid phase
separations (LLPS) with an *in vitro* transcribed 28-nt-long E3
(21) is observed for Loc1p concentrations >5 µM but not
in the absence of RNA (Supplementary Figure S6A). Further-
more, Loc1p stabilizes the energetically most favored confor-
mation of E3 in a time-course experiment with molecular bea-
cons and antisense RNA strands (Supplementary Figure S6B).
In summary, the PUN protein Loc1p drives RNA-dependent
phase separation and RNA annealing also on a physiological
target transcript.

PUN motifs are prevalent in nuclear proteins

To address whether PUN motifs are present in other pro-
teins in yeast, we performed a computational search in the
*S. cerevisiae* proteome (6060 proteins). Based on the obser-
vation that multiple PUN motifs are required for RNA chap-
erone activity and phase separation, we only considered pro-
teins with at least five PUN motifs in our search and three

or more PUN motifs in close proximity (termed PUN pro-
teins; see the ‘Materials and methods’ section). Intriguingly,
we identified a total of 95 PUN proteins that matched both cri-
teria, harboring up to 16 PUN motifs (Figure 6A and B, and
Supplementary Table S6). Relative to protein length, Loc1p
had the highest PUN motif density (eight PUN motifs in 204
aa) followed by Tma23p (six PUN motifs in 211 aa), Pxr1p
(six PUN motifs in 271 aa), Efg1p and Rpa34p (both five PUN
motifs in 233 aa; Figure 6B and E). Of note, the PUN proteins
have a higher degree of disorder than proteins without PUN
motifs, underlining the preference of PUN motifs for disor-
dered regions (Figure 6C). Eighty-four percent (80 out of 95)
of the PUN proteins had been reported to be located in the
nucleus (Figure 6D) (65), and nearly half of those were also
enriched within the nucleolus (37% of all PUN proteins), sup-
porting a role of PUN proteins in ribosome biogenesis. Indeed,
a functional enrichment analysis clearly showed an overrepre-
sentation in nucleic acid and RNA metabolic processes (Fig-
ure 6F), with 24 proteins being directly involved in ribosome
biogenesis. Consistently, related terms such as RNP complex
biogenesis, rRNA metabolic processes and rRNA processing
were also highly populated.

Interestingly, when we expanded our search to *S. pombe* and *D. melanogaster*, we found 61 and 349 PUN proteins, respectively, which were also predominantly located in the nucleus and enriched for similar functional terms (Supplementary Figure S7A and B, and Supplementary Tables S7 and S8). Likewise, even in the prokaryote *E. coli*, proteins containing at least three PUN motifs showed significant enrichment in similar processes (Supplementary Figure S7C and Supplementary Table S9), suggesting functionally conserved themes associated with PUN motifs. Finally, an analysis of the human proteome yielded 500 PUN proteins with five or more PUN motifs (Supplementary Figure S8A, B and E, and Supplementary Table S10). As for yeast, the human PUN proteins had a higher degree of disorder and were most often located in the nucleus (Supplementary Figure S8C and D). Additionally, the human PUN proteins showed strong enrichment in nucleic acid-related processes, including mRNA processing, RNP complex biogenesis, RNA splicing and nuclear speckles (Supplementary Figure S8F).

To evaluate how conserved the presence of PUN motifs
in proteins between distantly related species is, we iden-
tified orthologs of all 95 yeast PUN proteins in the hu-
man proteome (Supplementary Table S11). For ~36% of
these proteins, no ortholog could be found while roughly
35% have one (one-to-one) or more (one-to-many) orthologs
(Supplementary Figure S9A). From these orthologous human
proteins, about half fall into the definition of PUN proteins
(Supplementary Figure S9B). Further analysis showed that the
location, distribution and clustering of PUN motifs are simi-
lar between yeast PUN proteins and their human orthologs
(Supplementary Figure S9C).

The human PUN protein SRRM1 mediates
RNA-dependent phase separation

In order to experimentally assess whether human PUN pro-
teins bear the functional properties observed in Loc1p, we re-
combinantly expressed and purified a fragment of the human
SRRM1. SRRM1 is involved in mRNA processing and splic-
ing (66,67), rendering it an ideal candidate for comparing its
potential phase separation properties to Loc1p. The chosen
<figure><img src="image_13.png" /><figcaption>**Figure 6.** Yeast proteins containing the PUN motif identified in Loc1p are more likely to contain disordered regions, accumulate in the nucleus and are involved in RNA metabolic processes. (A) Computational identification of 95 proteins from *S. cerevisiae* that contain at least five PUN motifs, including at least three within 150 aa. (B) PUN motif density in the 95 yeast PUN proteins. Loc1p has the highest density of PUN motifs followed by Tma23p, Pxr1p, Efg1p and Rpa34p. (C) Yeast PUN proteins are characterized by a higher degree of disorderness compared to proteins without PUN motifs, reflecting the preference of PUN motifs for disordered regions. *P*-value is obtained from the Wilcoxon rank-sum test. (D) Analysis of the intracellular distribution of the 95 hits shows a clear preference for the nuclear (85%) and nucleolar (35%) compartments of the cell. (E) Distribution of PUN motifs in top five proteins from panel (B). (F) Functional enrichment analysis (GO) of annotated processes ordered by *P*-values. The RNA processing pathways are enriched in proteins bearing PUN motifs.</figcaption></figure>
SRRM1 fragment (aa 151–377) had a similar size and PUN motif content as Loc1p and was predicted to be intrinsically disordered (Supplementary Table S10). Its N-terminal folded PWI domain was excluded from the tested fragment. To test whether this SRRM1 fragment undergoes RNA-dependent phase separation, we performed titration experiments with total HeLa cell RNA followed by microscopic analyses. At protein/RNA ratios of 0.25 and 0.5, formation of condensates was observed at protein concentrations of 2.5–30 µM SRRM1 (Figure 7A and B). Also, in the inverse experiment, a titration of increasing amounts of RNA at a given SRRM1 concentration of 10 µM resulted in robust condensate formation (Figure 7C). These findings were cross-validated in centrifugation sedimentation experiments (Figure 7D). In none of the experiments, condensate formation or sedimentation was observed in the absence of RNA, demonstrating that SRRM1 is capable of RNA-dependent phase separation as observed for Loc1p.

## Discussion

Loc1p was reported to be a ribosome assembly factor that assists in the synthesis of the large ribosomal subunit leading to reduced levels of 80S ribosomes and accumulation of the 35S pre-rRNA in genomic LOC1 deletion strains (4,14,15). The presence of the aberrant 23S rRNA indicates that cleavage at the site A₃ is unaffected, whereas co-transcriptional processing at sites A₀, A₁ and A₂ is delayed. Thus, Loc1p is likely involved in early rRNA processing events. This interpretation is consistent with recent reports showing that Loc1p directly interacts with the ribosomal protein Rpl43 (13,14), as well as with other ribosome biogenesis factors and rRNA in the state E2 60S pre-ribosomal particle (12). Overall, the important role of Loc1p in ribosome biogenesis and the central importance of ribosomes for cell function are in line with the observed slow-growth phenotype of loc1Δ strains (Figure 1A) (56).

Using microarrays, we found that TAP-tagged Loc1p indeed co-purifies preferentially with rRNAs (Supplementary Figure S1A). Furthermore, recombinant Loc1p co-sediments with mature ribosomes (Figure 1B and C), which suggests that Loc1p directly interacts with immature and mature ribosomes in the nucleolus. The association with ribosomes of different kingdoms of life and its unspecific binding to single-stranded and double-stranded DNA and RNA (Figure 1D–F and Supplementary Figure S1B–E) suggest the recognition of general features of nucleic acids. Indeed, our ³¹P-NMR experiments are consistent with a direct interaction of Loc1p with the phosphoribose backbone (Supplementary Figure S4B). This might also explain why Loc1p is frequently found in immunoprecipitations of various RNPs (68,69). Within the cell, the nucleolar localization of Loc1p (15,65) might therefore be the main determinant of specificity for the process of ribosome biogenesis.

Using different chaperone assays, we showed that nucleic acid binding of Loc1p induces a strong annealing activity that even exceeds the activity of the well-studied U3 snoRNA–rRNA annealer Imp4p (Figure 2) (58,59). Subsequent NMR and SAXS analyses demonstrated that Loc1p is intrinsically disordered and lacks a globular domain fold (Figure 3A and B). Large parts of the unstructured Loc1p protein are involved in RNA binding (Figure 3C and D) through its PUN motifs (Figure 3E and Supplementary Figures S2 and S3A).

While a single motif is already capable of strand annealing, the combination of two or more PUN motifs leads to a drastic increase in annealing activity (Figure 4G and H), indicating that the motifs act with strong cooperativity. While wild-type Loc1p contains eight PUN motifs, a synthetic protein comprising 10 copies of its most N-terminal PUN motif [Loc1p (1–20)₁₀] yielded an annealing activity comparable to the wild-type protein (Figure 4G and H). This finding suggests that the iteration of PUN motifs is sufficient to recapitulate the folding catalyst activity of wild-type Loc1p.

An important question is how the activity of PUN motifs as folding catalyst is achieved at the molecular level. Our NMR experiments showed that a single PUN motif interacts with dsRNA, whereas peptides without a motif show considerably weaker binding (Figure 4A–D and Supplementary Figure S4A). The secondary structure of a dsRNA is not significantly altered upon PUN motif binding but the peptide itself gains rigidity (Figure 4F). Furthermore, the binding of the PUN motif results in the thermal stabilization of dsRNA (Figure 4C and D). Our ³¹P-NMR experiments are consistent with a direct interaction of the positively charged arginine/lysine side chains of the PUN motif with the phosphate groups of the dsRNA (Supplementary Figure S4B). The interaction still appears quite dynamic and no specific interaction is formed. This observation for PUN motifs is in contrast with other peptides that have been shown to bind to RNA hairpins (70,71). The dynamic and sequence-unspecific interaction is consistent with a potential chaperoning function of the PUN motif.

It has been shown that Loc1p and Puf6p form a ternary complex with the ribosomal protein Rpl43p and facilitate its loading onto the 60S ribosomal subunit (12,13). After this step, Loc1p and Puf6p are released. It is conceivable that Loc1p is required to assist correct folding of rRNAs to allow Rpl43p to be positioned correctly on the ribosomal subunit.

One interesting feature of PUN motifs is that each of the three repetitive units of one to three positively charged residues [RK](1,3) is interspaced by one to three residues that are not positively charged (RK)(1,3) (Figure 3E and Supplementary Figure S3D). Such spacing of positively charged side chains in PUN motifs is consistent with the spatial requirements for their interaction with the phosphoribose backbone of RNA (Figure 8). For example, the Cα atoms of two lysine residues spaced by one additional amino acid (e.g. K–X–K; Figure 8A) in an extended conformation span a distance of 6–7 Å. In fact, this is also the distance range between two neighboring phosphates of the phosphoribose moiety in single- and double-stranded DNA/RNA. In case of two adjacent lysines or arginines (e.g. K–K), their flexible, positively charged side chain may also bind to two consecutive phosphate groups (*cis* configuration, Figure 8B) or even phosphate groups of two different DNA or RNA strands (*trans* configuration, Figure 8C). Finally, a sequence of at least three consecutive lysine or arginine side chains (e.g. K–K–K; Figure 8D) may well explain the observed chaperone-like activity of PUN motifs. Since side chains of neighboring amino acids in an extended conformation usually point in opposite directions, two RNA/DNA strands may be connected by an interjacent amino acid stretch. The repetitive nature of PUN motifs in certain proteins allows for multivalent interactions, which is also suitable to explain the observed RNA-dependent phase separation of these proteins.

This sequence-unspecific binding mode suggests that the motif fulfills a very general molecular function and there-
<figure><img src="image_14.png" /><figcaption>**Figure 7.** Phase separation of human SRRM1 bearing 14 PUN motifs (Supplementary Table S10). SRRM1 undergoes RNA-dependent phase separation at protein concentrations of 2.5 µM or higher and at RNA:protein mass ratios of 0.5 (A) or 0.25 (B). Titration of increasing amounts of RNA and a constant concentration of 10 µM SRRM1 showed phase separation already at the lowest RNA:protein ratio. (D) RNA-dependent condensation of SRRM1 was confirmed by sedimentation experiments followed by SDS–PAGE stained by SyproRuby. Experiments shown in panels (A)–(D) were repeated at least once (n ≥ 2).</figcaption></figure>

fore might be a ubiquitous motif for sequence-independent RNA interactions. The folding catalyst activity and dsRNA-stabilizing functions of PUN motifs could in principle also support ribozymes other than the ribosome. Furthermore, the ability to undergo RNA-driven phase separation would potentially help such ribozymes to organize themselves in distinct functional foci in the cell, for instance, to locally concentrate their activities or recruit additional accessory factors.

In fact, we observed phase separation of Loc1p when mixed at concentrations of 5 µM or higher with total HeLa RNA. Since the formation of condensates depended on the protein concentration, we wondered whether the intranucleolar Loc1p concentration *in vivo* may be high enough to allow for phase separation. According to two different quantitative mass spectrometry studies, the theoretical nuclear Loc1p concentration is between 2 and 8 µM, calculated from the determined number of Loc1p molecules per cell and an average nuclear volume of 3 µm³ (72,73). Taking into account that the nucleolus occupies about one-third of the nuclear volume in yeast (74) and the predominant nucleolar localization of Loc1p, the concentration in the nucleolus is estimated to be

between 6 and 24 µM. Considering the formation of condensates at 5 µM Loc1p in our *in vitro* assay, it seems reasonable to speculate that Loc1p can also form biomolecular condensates with RNA in the yeast nucleolus at the calculated concentrations.

It is conceivable that the RNA-dependent phase separation of Loc1p helps increasing its local concentration in the nucleolus to a level where it catalyzes correct folding of rRNA to allow for efficient joining of Rpl43p in the ribosomal maturation process. Such a scenario is consistent with the observation that in a *loc1Δ* strain reduced 60S subunit levels (4) and a slow-growth phenotype are observed (Figure 1A) (15). Furthermore, the observed Loc1p-dependent folding catalysis and phase separation of the E3 localization element of the ASH1 mRNA (Supplementary Figure S6) indicate that Loc1p might assist co-transcriptional folding of transported RNAs into their energetically most favored state. Of note, the RNA polymerase II-associated mediator complex has been shown to assemble into phase-separated co-transcriptional complexes (75). It is tempting to speculate that for folding catalysis of the nascent ASH1 mRNA chain, the interaction of Loc1p with
<figure><img src="image_15.png" /><figcaption>**Figure 8.** Schematic model of possible interaction modes of PUN motifs with nucleic acids. Sequence-unspecific interactions with phosphodiester groups of nucleic acids are mediated by positively charged side chains. (A) Two positively charged amino acids separated by a single nonpositively charged amino acid have a distance that is very similar to the spacing of two neighboring phosphodiester groups in nucleic acids. Therefore, these two amino acids can potentially interact with two adjacent phosphodiesters. (B) Due to the lengths and flexibilities of the side chains of arginine and lysine, two neighboring amino acids can also interact with adjacent phosphodiesters of the same molecule (cis). (C) When pointing in opposite directions, two neighboring side chains can contact phosphodiester groups of two nucleic acid molecules (trans). (D) In a stretch of three consecutive arginines or lysines, these amino acids will also adopt a *trans* conformation. This feature should allow for the simultaneous contact of two nucleic acid molecules by one PUN motif. This arrangement likely constitutes an important feature for higher organization principles, including RNA annealing and RNA-dependent phase transition.</figcaption></figure>
<figure><img src="image_16.png" /><figcaption>**Figure 9.** Model of the effect of isolated and repeating PUN motifs on promiscuous folding of RNA molecules. (A) Isolated RNA (schematic stem-loop) may exist in an equilibrium of different secondary structures. (B) Binding of individual PUN motifs (red) to an RNA molecule stabilizes its energetically favored conformation. (C) A peptide chain with several PUN motifs acts cooperatively on RNA folding and facilitates the formation of condensates caused by their multivalent interactions.</figcaption></figure>

Spt5 (69) is supported by its phase-separating properties in the context of the RNA polymerase II-associated mediator complex.

In addition to Loc1p, other yeast proteins involved in RNA metabolism have been found to harbor RNA binding and annealing activities, which are not mediated by conventional/canonical, folded RNA-binding domains. For example, the mRNP packaging factor Yra1p and the mRNP biogenesis factor Tho2p possess RNA-annealing activities and contain intrinsically disordered regions (IDRs) interspersed with clusters of positively charged amino acids. Interestingly, the RNA-annealing properties of Yra1p and Tho2p lie in (map to) these positively charged IDRs that contain three and four PUN motifs, respectively (76–79).

EMSAs showed that the PUN protein Loc1p does not discriminate between RNA and DNA binding (Supplementary Figure S1B and C). It is therefore not surprising that proteins bearing PUN motifs are also found in DNA-related processes. For example, components of the chromatin re-modeling ISWI complex, different DNA helicases and topoisomerases show enrichment of PUN motifs in *S. cerevisiae* as well as *D. melanogaster* and humans (Supplementary Tables S6, S8 and S10). This conclusion is further supported by the fact that *S. cerevisiae*, *D. melanogaster* and even human histone H1 proteins contain multiple PUN motifs (Supplementary Table S10). Their predominantly unstructured regions are thought to interact via basic residues with chromatin, thus neutralizing the negative charge (80). Together with the globular domain of histone 1, this charge neutralization allows for the condensation of chromatin (81). The observation that PUN motifs mediate nucleic acid-dependent phase separation suggests that transcriptional regulation also involves distinct DNA-protein phases as proposed recently (82–84).

Of note, histone 1 is subjected to post-translational modifications such as phosphorylation, acetylation and methylation (85,86). These modifications often occur within or in close proximity to PUN motifs, for instance in human histone H1.4 (85) or in *S. cerevisiae* histone H1 (87–89). A negative charge like a phosphoserine/phosphothreonine or the removal of the positive charge of lysines by acetylation (acetyllysine) within or in close proximity to a PUN motif would alter the charge of this region and thereby might decrease its affinity to nucleic acids. We observed a similar affinity-modulating effect in PUN motifs of Loc1p. Here, negatively charged amino acids within or in close proximity to a PUN motif decreased its affinity to RNA (Supplementary Figure S2). Thus, post-translational modification might offer a way to modulate nucleic acid binding affinities of proteins containing multiple PUN motifs. This model is supported by a recent study, showing that lysine acetylation in disordered proteins can reverse RNA-dependent phase separation (90).

In the human proteome, we observed a considerable fraction of yeast PUN proteins to be conserved (Supplementary Figure S9). Furthermore, the strong accumulation of nucleic acid-related processes in the functional enrichment analysis of human PUN proteins (Supplementary Figure S8F) indicates a functional conservation of paralogs between distant species. Our observation that up to 15% of the mRNA-interacting human proteins (91,92) contain three or more PUN motifs (Supplementary Table S10) indicates that they play important roles in a large portion of the human RNA-binding proteins.

An important feature of PUN motifs is that they lack secondary structures. Thus, for PUN motifs to be active they would likely need to be located in disordered regions of these human proteins. Indeed, a systematic investigation of the secondary structure environment shows that proteins containing five or more PUN motifs display a higher degree of disorder-
ness compared to other proteins, reflecting the preference of the motifs for unfolded regions (Supplementary Figure S8C).

It has been proposed already several years ago that in an ancient RNA-dominated world short peptides might have helped to protect RNA against degradation and to stabilize defined RNA conformations (Figure 9) (93). This might have fostered the co-evolution of both types of molecules into functional RNPs. Accordingly, peptides are thought to have extended the structural and functional capabilities of RNAs and to facilitate the evolution of large RNPs such as ribosomes (94,95). It is therefore easy to envision how in an ancient RNA-dominated world ribozymes might have benefited from short, stabilizing peptides, such as the PUN motif. Several years ago, Herschlag et al. provided experimental support for this hypothesis. A hammerhead ribozyme, whose catalytic activity was impeded by mutations, was reactivated to cleave its substrate when a positively charged peptide was added (96).

However, it is much less clear what the direct benefit would have been in producing longer peptides that only later fold into small globular domains with more elaborate functions. For PUN motifs, we observed that the fusion of two entities already induces strong cooperativity with greatly enhanced RNA-annealing activity. Using the PUN motifs as a paradigm, it is tempting to speculate that the potentiation of such basic functions by multimerization provided an immediate evolutionary benefit that favored the production of longer peptide chains and helped to pave the way into a world where functional RNPs might have replaced an RNA-dominated world. Our study offers the insight that such motifs still fulfill similar functions in today's modern ribozymes, such as ribosomes, spliceosomes or RNases. For example, proteins associated with the yeast ribosome, such as ribosomal proteins L15 and L24 or numerous rRNA processing factors CGR1, RRP14, RRP5, RRP8, RRP3 and the ribosomal biogenesis protein BMS1, contain several PUN motifs. Similarly, the pre-mRNA splicing factor 8, CLF1 and YJU2 as well as the RNase P subunit POP1 include PUN motifs.

Furthermore, our results show that small RNA-binding motifs act cooperatively to catalyze RNA-based processes and at the same time can organize themselves into functional entities by phase separation (Figure 9). The latter has been described as organizing principle for a variety of cellular processes, including the formation of nuclear and cytosolic bodies, such as paraspeckles, the nucleolus and stress granules (97–100). In an ancient world, repetitive elements such as PUN motifs would have added the benefit of organizing RNA-protein complexes into higher-order entities via phase separation and thus more efficient catalysis of RNA-based reactions. It will be interesting to find out how prevalent short, disordered RNA-binding motifs with dual functions, such as RNA annealing and phase separation, are and which essential cellular functions they carry out in today's cells.

## Data availability

Microarray data are available for download via the PUMA database (http://puma.princeton.edu), experiment set no. 7342, and via Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo), experiment set no. GSE273374. Coordinates and structure factors have been deposited in the Protein Data Bank with the accession code 6YMC. The NMR chemical shift assignment of Loc1p (3–15) has been deposited at the BMRB with accession code 52416.

## Supplementary data

Supplementary Data are available at NAR Online.

## Acknowledgements

We would like to thank Vera Roman for her constant lab support and John Mattese from PUMAdb (http://puma.princeton.edu) for his important contribution. We acknowledge the use of the X-ray Crystallography Platform at the Institute of Structural Biology, Molecular Targets and Therapeutics Center, Helmholtz Munich. Moreover, we would like to thank the Core Facility Light Microscopy of the Medical Faculty at Ulm University and Dr Christian Bökel for providing his expertise and access to instrumentation funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), project number 257897648.

## Funding

Deutsche Forschungsgemeinschaft [FOR855 and FOR2333 to D.N., FOR2333 to K.Z., Emmy Noether Programme project number 246137224 to D.D.].

## Conflict of interest statement

None declared.

## References

1. Kressler,D., Hurt,E. and Bassler,J. (2010) Driving ribosome assembly. *Biochim. Biophys. Acta*, **1803**, 673-683.

2. Duss,O., Stepanyuk,G.A., Puglisi,J.D. and Williamson,J.R. (2019) Transient protein-RNA interactions guide nascent ribosomal RNA folding. *Cell*, **179**, 1357-1369.

3. Woolford,J.L. Jr and Baserga,S.J. (2013) Ribosome biogenesis in the yeast *Saccharomyces cerevisiae*. *Genetics*, **195**, 643-681.

4. Harnpicharnchai,P., Jakovljevic,J., Horsey,E., Miles,T., Roman,J., Rout,M., Meagher,D., Imai,B., Guo,Y., Brame,C.J., et al. (2001) Composition and functional characterization of yeast 66S ribosome assembly intermediates. *Mol. Cell*, **8**, 505-515.

5. Komili,S., Farny,N.G., Roth,F.P. and Silver,P.A. (2007) Functional specificity among ribosomal proteins regulates gene expression. *Cell*, **131**, 557-571.

6. Niedner,A., Muller,M., Moorthy,B.T., Jansen,R.P. and Niessing,D. (2013) Role of Loc1p in assembly and reorganization of nuclear ASH1 messenger ribonucleoprotein particles in yeast. *Proc. Natl Acad. Sci. U.S.A.*, **110**, E5049-E5058.

7. Shahbabian,K., Jeronimo,C., Forget,A., Robert,F. and Chartrand,P. (2014) Co-transcriptional recruitment of Puf6 by She2 couples translational repression to mRNA localization. *Nucleic Acids Res.*, **42**, 8692-8704.

8. Shen,Z., Paquin,N., Forget,A. and Chartrand,P. (2009) Nuclear shuttling of She2p couples ASH1 mRNA localization to its translational repression by recruiting Loc1p and Puf6p. *Mol. Biol. Cell*, **20**, 2265-2275.

9. De Marchis,M.L., Giorgi,A., Schinina,M.E., Bozzoni,I. and Fatica,A. (2005) Rrp15p, a novel component of pre-ribosomal particles required for 60S ribosome subunit maturation. *RNA*, **11**, 495-502.

10. Horsey,E.W., Jakovljevic,J., Miles,T.D., Harnpicharnchai,P. and Woolford,J.L. Jr (2004) Role of the yeast Rrp1 protein in the dynamics of pre-ribosome maturation. *RNA*, **10**, 813-827.

11. Saveanu,C., Namane,A., Gleizes,P.E., Lebreton,A., Rousselle,J.C., Noaillac-Depeyre,J., Gas,N., Jacquier,A. and Fromont-Racine,M. (2003) Sequential protein association with nascent 60S ribosomal particles. *Mol. Cell. Biol.*, **23**, 4449-4460.
12. Cruz,V.E., Sekulski,K., Peddada,N., Sailer,C., Balasubramanian,S., Weirich,C.S., Stengel,F. and Erzberger,J.P. (2022) Sequence-specific remodeling of a topologically complex RNP substrate by Spb4. *Nat. Struct. Mol. Biol.*, **29**, 1228–1238.

13. Liang,K.J., Yueh,L.Y., Hsu,N.H., Lai,J.S. and Lo,K.Y. (2019) Puf6 and Loc1 are the dedicated chaperones of ribosomal protein Rpl43 in *Saccharomyces cerevisiae*. *Int. J. Mol. Sci.*, **20**, 5941.

14. Yang,Y.T., Ting,Y.H., Liang,K.J. and Lo,K.Y. (2016) The roles of Puf6 and Loc1 in 60S biogenesis are interdependent, and both are required for efficient accommodation of Rpl43. *J. Biol. Chem.*, **291**, 19312–19323.

15. Urbinati,C.R., Gonsalvez,G.B., Aris,J.P. and Long,R.M. (2006) Loc1p is required for efficient assembly and nuclear export of the 60S ribosomal subunit. *Mol. Genet. Genomics*, **276**, 369–377.

16. Studier,F.W. (2005) Protein production by auto-induction in high density shaking cultures. *Protein Expr. Purif.*, **41**, 207–234.

17. Gerber,A.P., Herschlag,D. and Brown,P.O. (2004) Extensive association of functionally and cytotopically related mRNAs with Puf family RNA-binding proteins in yeast. *PLoS Biol.*, **2**, E79.

18. Hasegawa,Y., Irie,K. and Gerber,A.P. (2008) Distinct roles for Khd1p in the localization and expression of bud-localized mRNAs in yeast. *RNA*, **14**, 2333–2347.

19. Gollub,J., Ball,C.A., Binkley,G., Demeter,J., Finkelstein,D.B., Hebert,J.M., Hernandez-Boussard,T., Jin,H., Kaloper,M., Matese,J.C., et al. (2003) The Stanford Microarray Database: data access and quality assessment tools. *Nucleic Acids Res.*, **31**, 94–96.

20. Liao,Y., Wang,J., Jaehnig,E.J., Shi,Z. and Zhang,B. (2019) WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. *Nucleic Acids Res.*, **47**, W199–W205.

21. Edelmann,F.T., Niedner,A. and Niessing,D. (2014) Production of pure and functional RNA for *in vitro* reconstitution experiments. *Methods*, **65**, 333–341.

22. Hopkins,J.F., Panja,S., McNeil,S.A. and Woodson,S.A. (2009) Effect of salt and RNA structure on annealing and strand displacement by Hfq. *Nucleic Acids Res.*, **37**, 6205–6213.

23. Guichard,C., Ivanyi-Nagy,R., Sharma,K.K., Gabus,C., Marc,D., Mely,Y. and Darlix,J.L. (2011) Analysis of nucleic acid chaperoning by the prion protein and its inhibition by oligonucleotides. *Nucleic Acids Res.*, **39**, 8544–8558.

24. Delaglio,F., Grzesiek,S., Vuister,G.W., Zhu,G., Pfeifer,J. and Bax,A. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. *J. Biomol. NMR*, **6**, 277–293.

25. Johnson,B.A. and Blevins,R.A. (1994) NMR View: a computer program for the visualization and analysis of NMR data. *J. Biomol. NMR*, **4**, 603–614.

26. Wishart,D.S. and Sykes,B.D. (1994) The ¹³C chemical-shift index: a simple method for the identification of protein secondary structure using ¹³C chemical-shift data. *J. Biomol. NMR*, **4**, 171–180.

27. UniProt Consortium (2023) UniProt: the Universal Protein Knowledgebase in 2023. *Nucleic Acids Res.*, **51**, D523–D531.

28. Meszaros,B., Erdos,G. and Dosztanyi,Z. (2018) IUPred2A: context-dependent prediction of protein disorder as a function of redox state and protein binding. *Nucleic Acids Res.*, **46**, W329–W337.

29. McFadden,W.M. and Yanowitz,J.L. (2022) idpr: a package for profiling and analyzing intrinsically disordered proteins in R. *PLoS One*, **17**, e0266929.

30. Gene Ontology Consortium, Aleksander,S.A., Balhoff,J., Carbon,S., Cherry,J.M., Drabkin,H.J., Ebert,D., Feuermann,M., Gaudet,P., Harris,N.L., et al. (2023) The Gene Ontology Knowledgebase in 2023. *Genetics*, **224**, iyad031.

31. Wu,T., Hu,E., Xu,S., Chen,M., Guo,P., Dai,Z., Feng,T., Zhou,L., Tang,W., Zhan,L., et al. (2021) clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. *Innovation (Camb.)*, **2**, 100141.

32. Pagès,H., Carlson,M., Falcon,S. and Li,N. (2023) AnnotationDbi: manipulation of SQLite-based annotations in Bioconductor. *Bioconductor*, https://doi.org/10.18129/B9.bioc AnnotationDbi.

33. Bauer,S. and Gagneur,J. (2023) mgsa: model-based gene set analysis. Bioconductor, https://doi.org/10.18129/B9.bioc.mgsa.

34. Morrell,K. and Morgan,M. (2024) BiocSet: representing different biological sets. Bioconductor, https://doi.org/10.18129/B9.bioc.BiocSet.

35. Kinsella,R.J., Kahari,A., Haider,S., Zamora,J., Proctor,G., Spudich,G., Almeida-King,J., Staines,D., Derwent,P., Kerhornou,A., et al. (2011) Ensembl BioMarts: a hub for data retrieval across taxonomic space. *Database*, 2011, bar030.

36. Durinck,S., Moreau,Y., Kasprzyk,A., Davis,S., De Moor,B., Brazma,A. and Huber,W. (2005) BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis. *Bioinformatics*, **21**, 3439–3440.

37. Muller,M., Heym,R.G., Mayer,A., Kramer,K., Schmid,M., Cramer,P., Urlaub,H., Jansen,R.P. and Niessing,D. (2011) A cytoplasmic complex mediates specific mRNA recognition and localization in yeast. *PLoS Biol.*, **9**, e1000611.

38. Muller,M., Richter,K., Heuck,A., Kremmer,E., Buchner,J., Jansen,R.P. and Niessing,D. (2009) Formation of She2p tetramers is required for mRNA binding, mRNP assembly, and localization. *RNA*, **15**, 2002–2012.

39. Kabsch,W. (1993) Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. *J. Appl. Crystallogr.*, **26**, 795–800.

40. Evans,P. (2006) Scaling and assessment of data quality. *Acta Crystallogr. D Biol. Crystallogr.*, **62**, 72–82.

41. Winn,M.D., Ballard,C.C., Cowtan,K.D., Dodson,E.J., Emsley,P., Evans,P.R., Keegan,R.M., Krissinel,E.B., Leslie,A.G., McCoy,A., et al. (2011) Overview of the CCP4 suite and current developments. *Acta Crystallogr. D Biol. Crystallogr.*, **67**, 235–242.

42. French,S. and Wilson,K. (1978) On the treatment of negative intensity observations. *Acta Crystallogr.* A, **34**, 517–525.

43. Panjikar,S., Parthasarathy,V., Lamzin,V.S., Weiss,M.S. and Tucker,P.A. (2009) On the combination of molecular replacement and single-wavelength anomalous diffraction phasing for automated structure determination. *Acta Crystallogr. D Biol. Crystallogr.*, **65**, 1089–1097.

44. Panjikar,S., Parthasarathy,V., Lamzin,V.S., Weiss,M.S. and Tucker,P.A. (2005) Auto-Rickshaw: an automated crystal structure determination platform as an efficient tool for the validation of an X-ray diffraction experiment. *Acta Crystallogr. D Biol. Crystallogr.*, **61**, 449–457.

45. Collaborative Computational Project Number 4 (1994) The CCP4 Suite: programs for protein crystallography. *Acta Crystallogr. D Biol. Crystallogr.*, **50**, 760–763.

46. Sheldrick,G.M. (2010) Experimental phasing with SHELXC/D/E: combining chain tracing with density modification. *Acta Crystallogr. D Biol. Crystallogr.*, **66**, 479–485.

47. Hao,Q. (2004) ABS: a program to determine absolute configuration and evaluate anomalous scatterer substructure. *J. Appl. Crystallogr.*, **37**, 498–499.

48. Cowtan,K.D. and Zhang,K.Y. (1999) Density modification for macromolecular phase improvement. *Prog. Biophys. Mol. Biol.*, **72**, 245–270.

49. Morris,R.J., Zwart,P.H., Cohen,S., Fernandez,F.J., Kakaris,M., Kirillova,O., Vonrhein,C., Perrakis,A. and Lamzin,V.S. (2004) Breaking good resolutions with ARP/wARP. *J. Synchrotron Radiat.*, **11**, 56–59.

50. Perrakis,A., Harkiolaki,M., Wilson,K.S. and Lamzin,V.S. (2001) ARP/wARP and molecular replacement. *Acta Crystallogr. D Biol. Crystallogr.*, **57**, 1445–1450.

51. Emsley,P., Lohkamp,B., Scott,W.G. and Cowtan,K. (2010) Features and development of Coot. *Acta Crystallogr. D Biol. Crystallogr.*, **66**, 486–501.
52. Murshudov,G.N., Vagin,A.A. and Dodson,E.J. (1997) Refinement of macromolecular structures by the maximum-likelihood method. *Acta Crystallogr. D Biol. Crystallogr.*, **53**, 240–255.

53. Winn,M., Isupov,M. and Murshudov,G.N. (2000) Use of TLS parameters to model anisotropic displacements in macromolecular refinement. *Acta Crystallogr. D Biol. Crystallogr.*, **57**, 122–133.

54. Chen,V.B., Arendall,W.B. 3rd, Headd,J.J., Keedy,D.A., Immormino,R.M., Kapral,G.J., Murray,L.W., Richardson,J.S. and Richardson,D.C. (2010) MolProbity: all-atom structure validation for macromolecular crystallography. *Acta Crystallogr. D Biol. Crystallogr.*, **66**, 12–21.

55. Konarev,P.V., Petoukhov,M.V., Volkov,V.V. and Svergun,D.I. (2006) ATSAS2.1, a program package for small-angle scattering data analysis. *J. Appl. Crystallogr.*, **39**, 277–286.

56. Long,R.M., Gu,W., Meng,X., Gonsalvez,G., Singer,R.H. and Chartrand,P. (2001) An exclusively nuclear RNA-binding protein affects asymmetric localization of ASH1 mRNA and Ash1p in yeast. *J. Cell Biol.*, **153**, 307–318.

57. Bernacchi,S. and Mely,Y. (2001) Exciton interaction in molecular beacons: a sensitive sensor for short range modifications of the nucleic acid structure. *Nucleic Acids Res.*, **29**, E62-2.

58. Gerczei,T. and Correll,C.C. (2004) Imp3p and Imp4p mediate formation of essential U3-precursor rRNA (pre-rRNA) duplexes, possibly to recruit the small subunit processome to the pre-rRNA. *Proc. Natl Acad. Sci. U.S.A.*, **101**, 15301–15306.

59. Gerczei,T., Shah,B.N., Manzo,A.J., Walter,N.G. and Correll,C.C. (2009) RNA chaperones stimulate formation and yield of the U3 snoRNA–pre-rRNA duplexes needed for eukaryotic ribosome biogenesis. *J. Mol. Biol.*, **390**, 991–1006.

60. Doetsch,M., Stampfl,S., Furtig,B., Beich-Frandsen,M., Saxena,K., Lybecker,M. and Schroeder,R. (2013) Study of *E. coli* Hfq's RNA annealing acceleration and duplex destabilization activities using substrates with different GC-contents. *Nucleic Acids Res.*, **41**, 487–497.

61. Sawyer,I.A., Sturgill,D. and Dundr,M. (2019) Membraneless nuclear organelles and the search for phases within phases. *Wiley Interdiscip. Rev. RNA*, **10**, e1514.

62. Alberti,S. (2017) Phase separation in biology. *Curr. Biol.*, **27**, R1097–R1102.

63. Banani,S.F., Lee,H.O., Hyman,A.A. and Rosen,M.K. (2017) Biomolecular condensates: organizers of cellular biochemistry. *Nat. Rev. Mol. Cell Biol.*, **18**, 285–298.

64. Corbet,G.A. and Parker,R. (2019) RNP granule formation: lessons from P-bodies and stress granules. *Cold Spring Harbor Symp. Quant. Biol.*, **84**, 203–215.

65. Huh,W.K., Falvo,J.V., Gerke,L.C., Carroll,A.S., Howson,R.W., Weissman,J.S. and O'Shea,E.K. (2003) Global analysis of protein localization in budding yeast. *Nature*, **425**, 686–691.

66. Blencowe,B.J., Issner,R., Nickerson,J.A. and Sharp,P.A. (1998) A coactivator of pre-mRNA splicing. *Genes Dev.*, **12**, 996–1009.

67. McCracken,S., Longman,D., Johnstone,I.L., Caceres,J.F. and Blencowe,B.J. (2003) An evolutionarily conserved role for SRm160 in 3'-end processing that functions independently of exon junction complex formation. *J. Biol. Chem.*, **278**, 44153–44160.

68. Ho,Y., Gruhler,A., Heilbut,A., Bader,G.D., Moore,L., Adams,S.L., Millar,A., Taylor,P., Bennett,K., Boutilier,K., et al. (2002) Systematic identification of protein complexes in *Saccharomyces cerevisiae* by mass spectrometry. *Nature*, **415**, 180–183.

69. Lindstrom,D.L., Squazzo,S.L., Muster,N., Burckin,T.A., Wachter,K.C., Emigh,C.A., McCleery,J.A., Yates,J.R. 3rd and Hartzog,G.A. (2003) Dual roles for Spt5 in pre-mRNA processing and transcription elongation revealed by identification of Spt5-associated proteins. *Mol. Cell. Biol.*, **23**, 1370–1378.

70. Battiste,J.L., Mao,H., Rao,N.S., Tan,R., Muhandiram,D.R., Kay,L.E., Frankel,A.D. and Williamson,J.R. (1996) Alpha helix–RNA major groove recognition in an HIV-1 Rev peptide–RRE RNA complex. *Science*, **275**, 1547–1551.

71. Ye,X., Gorin,A., Ellington,A.D. and Patel,D.J. (1996) Deep penetration of an alpha-helix into a widened RNA major groove in the HIV-1 rev peptide–RNA aptamer complex. *Nat. Struct. Biol.*, **3**, 1026–1033.

72. Kulak,N.A., Pichler,G., Paron,I., Nagaraj,N. and Mann,M. (2014) Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells. *Nat. Methods*, **11**, 319–324.

73. Picotti,P., Bodenmiller,B., Mueller,L.N., Domon,B. and Aebersold,R. (2009) Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics. *Cell*, **138**, 795–806.

74. Matos-Perdomo,E. and Machin,F. (2019) Nucleolar and ribosomal DNA structure under stress: yeast lessons for aging and cancer. *Cells*, **8**, 779.

75. Richter,W.F., Nayak,S., Iwasa,J. and Taatjes,D.J. (2022) The Mediator complex as a master regulator of transcription by RNA polymerase II. *Nat. Rev. Mol. Cell Biol.*, **23**, 732–749.

76. Bonneau,F., Basquin,J., Steigenberger,B., Schafer,T., Schafer,I.B. and Conti,E. (2023) Nuclear mRNPs are compact particles packaged with a network of proteins promoting RNA–RNA interactions. *Genes Dev.*, **37**, 505–517.

77. Keil,P., Wulf,A., Kachariya,N., Reuscher,S., Huhn,K., Silbern,I., Altmuller,J., Keller,M., Stehle,R., Zarnack,K., et al. (2023) Npl3 functions in mRNP assembly by recruitment of mRNP components to the transcription site and their transfer onto the mRNA. *Nucleic Acids Res.*, **51**, 831–851.

78. Pena,A., Gewartowski,K., Mroczek,S., Cuellar,J., Szykowska,A., Prokop,A., Czarnocki-Cieciura,M., Piwowarski,J., Tous,C., Aguilera,A., et al. (2012) Architecture and nucleic acids recognition mechanism of the THO complex, an mRNP assembly factor. *EMBO J.*, **31**, 1605–1616.

79. Zenklusen,D., Vinciguerra,P., Strahm,Y. and Stutz,F. (2001) The yeast hnRNP-like proteins Yra1p and Yra2p participate in mRNA export through interaction with Mex67p. *Mol. Cell. Biol.*, **21**, 4219–4232.

80. Roque,A., Ponte,I. and Suau,P. (2016) Interplay between histone H1 structure and function. *Biochim. Biophys. Acta*, **1859**, 444–454.

81. Gibson,B.A., Doolittle,L.K., Schneider,M.W.G., Jensen,L.E., Gamarra,N., Henry,L., Gerlich,D.W., Redding,S. and Rosen,M.K. (2019) Organization of chromatin by intrinsic and regulated phase separation. *Cell*, **181**, 470–484.e21.

82. Boija,A., Klein,I.A., Sabari,B.R., Dall'Agnese,A., Coffey,E.L., Zamudio,A.V., Li,C.H., Shrinivas,K., Manteiga,J.C., Hannett,N.M., et al. (2018) Transcription factors activate genes through the phase-separation capacity of their activation domains. *Cell*, **175**, 1842–1855.e16.

83. Guo,Y.E., Manteiga,J.C., Henninger,J.E., Sabari,B.R., Dall'Agnese,A., Hannett,N.M., Spille,J.H., Afeyan,L.K., Zamudio,A.V., Shrinivas,K., et al. (2019) Pol II phosphorylation regulates a switch between transcriptional and splicing condensates. *Nature*, **572**, 543–548.

84. Hnisz,D., Shrinivas,K., Young,R.A., Chakraborty,A.K. and Sharp,P.A. (2017) A phase separation model for transcriptional control. *Cell*, **169**, 13–23.

85. Hergeth,S.P. and Schneider,R. (2015) The H1 linker histones: multifunctional proteins beyond the nucleosomal core particle. *EMBO Rep.*, **16**, 1439–1453.

86. Izzo,A. and Schneider,R. (2016) The role of linker histone H1 modifications in the regulation of gene expression and chromatin dynamics. *Biochim. Biophys. Acta*, **1859**, 488–495.

87. Albuquerque,C.P., Smolka,M.B., Payne,S.H., Bafna,V., Eng,J. and Zhou,H. (2008) A multidimensional chromatography technology for in-depth phosphoproteome analysis. *Mol. Cell. Proteomics*, **7**, 1389–1396.

88. Soulard,A., Cremonesi,A., Moes,S., Schutz,F., Jeno,P. and Hall,M.N. (2010) The rapamycin-sensitive phosphoproteome reveals that TOR controls protein kinase A toward some but not all substrates. *Mol. Biol. Cell*, **21**, 3475–3486.
89. Swaney,D.L., Beltrao,P., Starita,L., Guo,A., Rush,J., Fields,S., Krogan,N.J. and Villen,J. (2013) Global analysis of phosphorylation and ubiquitylation cross-talk in protein degradation. *Nat. Methods*, **10**, 676-682.

90. Ukmar-Godec,T., Hutten,S., Grieshop,M.P., Rezaei-Ghaleh,N., Cima-Omori,M.S., Biernat,J., Mandelkow,E., Soding,J., Dormann,D. and Zweckstetter,M. (2019) Lysine/RNA-interactions drive and regulate biomolecular condensation. *Nat. Commun.*, **10**, 2909.

91. Baltz,A.G., Munschauer,M., Schwanhausser,B., Vasile,A., Murakawa,Y., Schueler,M., Youngs,N., Penfold-Brown,D., Drew,K., Milek,M., et al. (2012) The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. *Mol. Cell*, **46**, 674-690.

92. Castello,A., Fischer,B., Frese,C.K., Horos,R., Alleaume,A.M., Foehr,S., Curk,T., Krijgsveld,J. and Hentze,M.W. (2016) Comprehensive identification of RNA-binding domains in human cells. *Mol. Cell*, **63**, 696-710.

93. Poole,A.M., Jeffares,D.C. and Penny,D. (1998) The path from the RNA world. *J. Mol. Evol.*, **46**, 1-17.

94. Cech,T.R. (2009) Crawling out of the RNA world. *Cell*, **136**, 599-602.

95. Noller,H.F. (2004) The driving force for molecular evolution of translation. *RNA*, **10**, 1833-1837.

96. Herschlag,D., Khosla,M., Tsuchihashi,Z. and Karpel,R.L. (1994) An RNA chaperone activity of non-specific RNA binding proteins in hammerhead ribozyme catalysis. *EMBO J.*, **13**, 2913-2924.

97. Stanek,D. and Fox,A.H. (2017) Nuclear bodies: news insights into structure and function. *Curr. Opin. Cell Biol.*, **46**, 94-101.

98. Cirillo,L., Cieren,A., Barbieri,S., Khong,A., Schwager,F., Parker,R. and Gotta,M. (2020) UBAP2L forms distinct cores that act in nucleating stress granules upstream of G3BP1. *Curr. Biol.*, **30**, 699-707.

99. Lin,Y., Protter,D.S., Rosen,M.K. and Parker,R. (2015) Formation and maturation of phase-separated liquid droplets by RNA-binding proteins. *Mol. Cell*, **60**, 208-219.

100. Zhang,B. and Herman,P.K. (2020) It is all about the process(ing): P-body granules and the regulation of signal transduction. *Curr. Genet.*, **66**, 73-77.